Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	RGPD1 TBC1D9 GBP5 TBC1D12 SESN2 RGL2 RASAL1 AGAP1 DOCK3 IQSEC3 IPO7 PLEKHG4 STXBP5L ARHGEF12 ARHGEF18 ARHGAP6 ARHGEF40 RASGEF1B DEPDC1B ARHGAP19 SOS1	1.71e-05	507	289	21	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	RGPD1 TBC1D9 GBP5 TBC1D12 SESN2 RGL2 RASAL1 AGAP1 DOCK3 IQSEC3 IPO7 PLEKHG4 STXBP5L ARHGEF12 ARHGEF18 ARHGAP6 ARHGEF40 RASGEF1B DEPDC1B ARHGAP19 SOS1	1.71e-05	507	289	21	GO:0030695
GeneOntologyMolecularFunction	calcium ion binding	CDH23 ADGRV1 PKD1L2 ITGB1 ITIH1 TBC1D9 FAT2 PCDH11X PCDH15 FAT4 DSC3 PCDHGB7 PCDHGB3 PCDHGA7 PCLO PCDHB7 PCDHAC1 CDH19 THBS4 P4HTM CELSR3 PCDHGA12 PCDHGB4 MACF1 PCDH9 CDH17	3.70e-05	749	289	26	GO:0005509
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	CDH23 ITGB1 FAT2 PCDH11X PCDH15 FAT4 DSC3 PCDHGB7 PCDHGB3 PCDHGA7 PCDHB7 PCDHAC1 CDH19 NPTN CELSR3 PCDHGA12 PCDHGB4 PCDH9 PALLD CDH17	2.41e-12	187	291	20	GO:0007156
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	MCAM CDH23 ITGB1 FAT2 PCDH11X PCDH15 FAT4 DSC3 PCDHGB7 PCDHGB3 PCDHGA7 PCDHB7 PCDHAC1 CDH19 NPTN CELSR3 PCDHGA12 PCDHGB4 PCDH9 PALLD CDH17	4.19e-09	313	291	21	GO:0098742
GeneOntologyBiologicalProcess	cell-cell adhesion	MCAM CDH23 ADGRV1 GFUS ITGAV ITGB1 PTPN2 FAT2 PCDH11X PCDH15 DLG2 NPHS1 FAT4 DSC3 PCDHGB7 PCDHGB3 PRICKLE1 PCDHGA7 MAP3K8 PCDHB7 PCDHAC1 FNDC3A CDH19 CYFIP2 NPTN THBS4 CELSR3 PCDHGA12 PCDHGB4 ELANE PCDH9 PALLD CDH17 TJP3	9.87e-06	1077	291	34	GO:0098609
Domain	Cadherin_CS	CDH23 FAT2 PCDH11X PCDH15 FAT4 DSC3 PCDHGB7 PCDHGB3 PCDHGA7 PCDHB7 PCDHAC1 CDH19 CELSR3 PCDHGA12 PCDHGB4 PCDH9 CDH17	7.58e-13	109	285	17	IPR020894
Domain	CADHERIN_1	CDH23 FAT2 PCDH11X PCDH15 FAT4 DSC3 PCDHGB7 PCDHGB3 PCDHGA7 PCDHB7 PCDHAC1 CDH19 CELSR3 PCDHGA12 PCDHGB4 PCDH9 CDH17	1.39e-12	113	285	17	PS00232
Domain	Cadherin	CDH23 FAT2 PCDH11X PCDH15 FAT4 DSC3 PCDHGB7 PCDHGB3 PCDHGA7 PCDHB7 PCDHAC1 CDH19 CELSR3 PCDHGA12 PCDHGB4 PCDH9 CDH17	1.39e-12	113	285	17	PF00028
Domain	-	CDH23 FAT2 PCDH11X PCDH15 FAT4 DSC3 PCDHGB7 PCDHGB3 PCDHGA7 PCDHB7 PCDHAC1 CDH19 CELSR3 PCDHGA12 PCDHGB4 PCDH9 CDH17	1.61e-12	114	285	17	2.60.40.60
Domain	CADHERIN_2	CDH23 FAT2 PCDH11X PCDH15 FAT4 DSC3 PCDHGB7 PCDHGB3 PCDHGA7 PCDHB7 PCDHAC1 CDH19 CELSR3 PCDHGA12 PCDHGB4 PCDH9 CDH17	1.61e-12	114	285	17	PS50268
Domain	CA	CDH23 FAT2 PCDH11X PCDH15 FAT4 DSC3 PCDHGB7 PCDHGB3 PCDHGA7 PCDHB7 PCDHAC1 CDH19 CELSR3 PCDHGA12 PCDHGB4 PCDH9 CDH17	1.87e-12	115	285	17	SM00112
Domain	Cadherin-like	CDH23 FAT2 PCDH11X PCDH15 FAT4 DSC3 PCDHGB7 PCDHGB3 PCDHGA7 PCDHB7 PCDHAC1 CDH19 CELSR3 PCDHGA12 PCDHGB4 PCDH9 CDH17	2.16e-12	116	285	17	IPR015919
Domain	Cadherin	CDH23 FAT2 PCDH11X PCDH15 FAT4 DSC3 PCDHGB7 PCDHGB3 PCDHGA7 PCDHB7 PCDHAC1 CDH19 CELSR3 PCDHGA12 PCDHGB4 PCDH9 CDH17	2.87e-12	118	285	17	IPR002126
Domain	Cadherin_2	PCDH11X PCDHGB7 PCDHGB3 PCDHGA7 PCDHB7 PCDHAC1 PCDHGA12 PCDHGB4 PCDH9	5.98e-07	65	285	9	PF08266
Domain	Cadherin_N	PCDH11X PCDHGB7 PCDHGB3 PCDHGA7 PCDHB7 PCDHAC1 PCDHGA12 PCDHGB4 PCDH9	5.98e-07	65	285	9	IPR013164
Domain	Cadherin_C	PCDHGB7 PCDHGB3 PCDHGA7 PCDHB7 PCDHAC1 PCDHGA12 PCDHGB4	3.06e-06	42	285	7	IPR032455
Domain	Cadherin_C_2	PCDHGB7 PCDHGB3 PCDHGA7 PCDHB7 PCDHAC1 PCDHGA12 PCDHGB4	3.06e-06	42	285	7	PF16492
Domain	Transcription_factor_COE	EBF2 EBF3 EBF1	1.39e-05	4	285	3	IPR003523
Domain	COE	EBF2 EBF3 EBF1	1.39e-05	4	285	3	PS01345
Domain	COE_HLH	EBF2 EBF3 EBF1	1.39e-05	4	285	3	IPR032201
Domain	COE_DBD	EBF2 EBF3 EBF1	1.39e-05	4	285	3	IPR032200
Domain	Transcription_factor_COE_CS	EBF2 EBF3 EBF1	1.39e-05	4	285	3	IPR018350
Domain	COE1_HLH	EBF2 EBF3 EBF1	1.39e-05	4	285	3	PF16423
Domain	COE1_DBD	EBF2 EBF3 EBF1	1.39e-05	4	285	3	PF16422
Domain	-	CACNA2D2 COL22A1 ITGB1 ITIH1 INTS6L CACNA2D1 COL7A1 VWF	1.68e-05	74	285	8	3.40.50.410
Domain	Cadherin_tail	PCDHGB7 PCDHGB3 PCDHGA7 PCDHAC1 PCDHGA12 PCDHGB4	1.87e-05	37	285	6	PF15974
Domain	Cadherin_CBD	PCDHGB7 PCDHGB3 PCDHGA7 PCDHAC1 PCDHGA12 PCDHGB4	1.87e-05	37	285	6	IPR031904
Domain	VWFA	CACNA2D2 COL22A1 ITGB1 ITIH1 INTS6L CACNA2D1 COL7A1 VWF	3.57e-05	82	285	8	PS50234
Domain	VWA	CACNA2D2 COL22A1 ITGB1 ITIH1 INTS6L CACNA2D1 COL7A1 VWF	4.26e-05	84	285	8	SM00327
Domain	-	NUGGC RHOJ MFHAS1 CARD10 AK9 SRCAP DCK DDX3X AK3 HNRNPU ABCB4 GBP5 SEPTIN14 DLG2 ASCC3 GNL1 DDX4 AGAP1 ABCB5 SBNO2 RIT2 EEF2 MTREX SNRNP200 MX2 TJP3	8.17e-05	746	285	26	3.40.50.300
Domain	P-loop_NTPase	NUGGC MYO5B RHOJ MFHAS1 CARD10 AK9 SRCAP DCK DDX3X AK3 HNRNPU ABCB4 SPATA17 GBP5 SEPTIN14 DLG2 ASCC3 GNL1 DDX4 AGAP1 ABCB5 SBNO2 RIT2 EEF2 MTREX SNRNP200 MX2 TJP3	1.09e-04	848	285	28	IPR027417
Domain	VWF_A	CACNA2D2 COL22A1 ITGB1 ITIH1 INTS6L CACNA2D1 COL7A1 VWF	1.37e-04	99	285	8	IPR002035
Domain	Ig_I-set	IGFN1 ISLR MERTK SIGLEC12 NPHS1 LRRN1 NPTN CD22 UNC5C PALLD ALPK2	1.68e-04	190	285	11	IPR013098
Domain	I-set	IGFN1 ISLR MERTK SIGLEC12 NPHS1 LRRN1 NPTN CD22 UNC5C PALLD ALPK2	1.68e-04	190	285	11	PF07679
Domain	VWA	CACNA2D2 COL22A1 ITIH1 CACNA2D1 COL7A1 VWF	2.05e-04	56	285	6	PF00092
Domain	PH_dom-like	RGPD1 LYST PTK2B OSBPL1A PLD1 RASAL1 AGAP1 IQSEC3 PLEKHG4 VEPH1 ARHGEF12 ARHGEF18 PPP4R3B ARHGEF40 APPL1 GAB1 SOS1	3.13e-04	426	285	17	IPR011993
Domain	PH	OSBPL1A PLD1 RASAL1 AGAP1 IQSEC3 PLEKHG4 VEPH1 ARHGEF12 ARHGEF18 ARHGEF40 APPL1 GAB1 SOS1	3.64e-04	278	285	13	SM00233
Domain	Spectrin	SPTB SYNE2 UTRN MACF1	3.74e-04	23	285	4	PF00435
Domain	ACTININ_2	SPTB SYNE2 UTRN MACF1	3.74e-04	23	285	4	PS00020
Domain	ACTININ_1	SPTB SYNE2 UTRN MACF1	3.74e-04	23	285	4	PS00019
Domain	Actinin_actin-bd_CS	SPTB SYNE2 UTRN MACF1	3.74e-04	23	285	4	IPR001589
Domain	PH_DOMAIN	OSBPL1A PLD1 RASAL1 AGAP1 IQSEC3 PLEKHG4 VEPH1 ARHGEF12 ARHGEF18 ARHGEF40 APPL1 GAB1 SOS1	3.76e-04	279	285	13	PS50003
Domain	PH_domain	OSBPL1A PLD1 RASAL1 AGAP1 IQSEC3 PLEKHG4 VEPH1 ARHGEF12 ARHGEF18 ARHGEF40 APPL1 GAB1 SOS1	3.89e-04	280	285	13	IPR001849
Domain	Cse1	IPO8 IPO7	6.89e-04	3	285	2	PF08506
Domain	Cse1	IPO8 IPO7	6.89e-04	3	285	2	IPR013713
Domain	B2-adapt-app_C	AP2B1 AP4B1	6.89e-04	3	285	2	PF09066
Domain	AP_complex_bsu_1_2_4	AP2B1 AP4B1	6.89e-04	3	285	2	IPR016342
Domain	ARM-type_fold	IFT172 LYST AP2B1 AP1G1 ARMC8 DOCK3 IPO8 IPO7 TTI2 VEPH1 APOB PPP4R3B PPP2R1A AP4B1	7.53e-04	339	285	14	IPR016024
Domain	Spectrin_repeat	SPTB SYNE2 UTRN MACF1	9.33e-04	29	285	4	IPR002017
Domain	IGc2	IGFN1 MCAM ISLR SIGLEC12 NPHS1 LRRN1 NPTN CD22 UNC5C PALLD ALPK2	1.01e-03	235	285	11	SM00408
Domain	Ig_sub2	IGFN1 MCAM ISLR SIGLEC12 NPHS1 LRRN1 NPTN CD22 UNC5C PALLD ALPK2	1.01e-03	235	285	11	IPR003598
Domain	-	RGPD1 OSBPL1A PLD1 RASAL1 AGAP1 IQSEC3 PLEKHG4 VEPH1 ARHGEF12 ARHGEF18 PPP4R3B ARHGEF40 APPL1 GAB1 SOS1	1.04e-03	391	285	15	2.30.29.30
Domain	Ig_E-set	CPAMD8 EBF2 KCNJ2 ASCC3 EBF3 EBF1 SNRNP200	1.08e-03	104	285	7	IPR014756
Domain	Ras_G-nucl-exch_fac_CS	RGL2 RASGEF1B SOS1	1.13e-03	14	285	3	IPR019804
Domain	SPEC	SPTB SYNE2 UTRN MACF1	1.36e-03	32	285	4	SM00150
Domain	Spectrin/alpha-actinin	SPTB SYNE2 UTRN MACF1	1.36e-03	32	285	4	IPR018159
Domain	Sec63	ASCC3 SNRNP200	1.36e-03	4	285	2	PF02889
Domain	Sec63	ASCC3 SNRNP200	1.36e-03	4	285	2	SM00973
Domain	Sec63-dom	ASCC3 SNRNP200	1.36e-03	4	285	2	IPR004179
Domain	B2-adapt-app_C	AP2B1 AP4B1	1.36e-03	4	285	2	SM01020
Domain	B-adaptin_app_sub_C	AP2B1 AP4B1	1.36e-03	4	285	2	IPR015151
Domain	VDCC_a2/dsu	CACNA2D2 CACNA2D1	1.36e-03	4	285	2	IPR013680
Domain	Aldehyde_DH_NAD(P)	ALDH3B1 ALDH3B2	1.36e-03	4	285	2	IPR012394
Domain	VGCC_alpha2	CACNA2D2 CACNA2D1	1.36e-03	4	285	2	PF08473
Domain	Adaptin_N	AP2B1 AP1G1 AP4B1	1.40e-03	15	285	3	PF01602
Domain	Clathrin/coatomer_adapt-like_N	AP2B1 AP1G1 AP4B1	1.40e-03	15	285	3	IPR002553
Domain	GPS	ADGRV1 PKD1L2 CELSR3 ADGRD2	1.72e-03	34	285	4	SM00303
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ATP8B4 MYO5B TBC1D9 RFTN1 FAT2 RIMKLB NUP210 TMEM132A SCAPER TBC1D12 GRIN3A SEC14L1 DOCK3 SEC16B MAN2B2 LRRN1 SYNM ARHGEF18 TTC21B MACF1 APPL1 MORC3 EMC2 SNRNP200 PALLD	1.24e-12	493	295	25	15368895
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	MYO5B RGPD1 PHB2 SRCAP LYST FER1L6 HNRNPU ABCB4 RFTN1 RIMKLB AP2B1 FUBP1 SYNE2 DLG2 CTAGE4 USP1 SMURF2 ERICH6 DYNC1I2 SLC27A4 PCDHGB7 PCDHGB3 PCDHGA7 ABCB5 PCLO APOB CYFIP2 SPATC1 EEF2 TRAP1 RNF2 PCDHGA12 UNC5C CTAGE8 PCDHGB4 MACF1 IFT122 EIF2AK4 EMC2 RBFA	5.11e-11	1442	295	40	35575683
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	FAT2 PCDH11X PCDHGB7 PCDHGB3 PCDHGA7 PCDHB7 PCDHAC1 CELSR3 PCDHGA12 PCDHGB4 PCDH9	8.46e-11	80	295	11	10716726
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	SELENOT ZNF131 PHB2 ITGB1 SLC38A2 PTPN2 HSPA12A KIDINS220 P3H1 SYNE2 NUP210 RWDD1 ASCC2 DNAJC24 FKBP8 ASCC3 PIH1D1 USP48 RAD21 IPO8 IPO7 DSC3 SYNM KIAA1549 FNDC3A OAT CEP192 PAF1 PREPL MAPRE1 AIFM2 MACF1 LSS IFT122 TYW1 EMC2 SNRNP200 DEPDC1B GAB1	4.59e-10	1487	295	39	33957083
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	FAT2 PCDH11X PCDHGB7 PCDHGB3 PCDHGA7 PCDHB7 PCDHAC1 PCDHGA12 PCDHGB4 PCDH9	1.10e-09	77	295	10	10835267
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	ATP8B4 CACNA2D2 PHB2 MAST2 DDX3X PRDM2 HNRNPU FANCD2 SLC38A2 RBM25 KIDINS220 AP1G1 FUBP1 NUP210 SLC27A4 MGAM2 ARMC8 RAD21 USP36 PSAT1 EXOSC9 IPO8 IPO7 PCLO PPIL4 OAT APOB CYFIP2 MAPRE1 PPP2R1A EEF2 TRAP1 RNF2 CSTF3 MTREX EMC2 SNRNP200	1.76e-09	1425	295	37	30948266
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	MYO5B MCAM ITGB1 FANCD2 PHKB PTPN2 RFTN1 HSPA12A STYX P3H1 SYNE2 NUP210 FKBP8 PIH1D1 USP1 UTRN USP36 PSAT1 IPO7 DSC3 PPM1E KIAA1549 CEP192 PAF1 CYFIP2 PPP4R3B PPP2R1A GTF2E1 CSTF3 EIF2AK4 GAB1	2.07e-09	1049	295	31	27880917
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	RPS6KA2 RGPD1 PHB2 ITIH1 DDX3X HNRNPU AP2B1 CAMKV SYNE2 DLG2 RASAL1 ARMC8 CACNA2D1 IQSEC3 EBF3 ARHGEF12 ARHGEF18 PAF1 PREPL CYFIP2 NPTN PPP2R1A FRY EEF2 STON2 NT5C2 ANKRD17 MACF1 APPL1	4.67e-09	963	295	29	28671696
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	ZNF234 IFT172 SPTB LRSAM1 DDX3X AP2B1 OSBPL1A DLG2 MERTK MVP UTRN SMURF2 AGAP1 ARMC8 DOCK3 EXOSC9 VWF FN1 SYNM JADE2 OAT PREPL PPP4R3B FRY EEF2 P4HTM CELSR3 DCTN6 MACF1 APPL1 IFT122 MORC3 SNRNP200 SOS1	5.33e-09	1285	295	34	35914814
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	FAT2 PCDHGB7 PCDHGB3 PCDHGA7 PCDHB7 PCDHAC1 CELSR3 PCDHGA12 PCDHGB4	1.07e-08	72	295	9	10380929
Pubmed	Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.	PCDH11X PCDHGB7 PCDHGB3 PCDHGA7 PCDHB7 PCDHAC1 PCDHGA12 PCDHGB4 PCDH9	1.37e-08	74	295	9	10817752
Pubmed	Proteomic Analysis Reveals a Role for RSK in p120-catenin Phosphorylation and Melanoma Cell-Cell Adhesion.	RPS6KA2 RGPD1 MCAM ITGB1 SLC38A2 RAD21 IPO8 IPO7 ARHGEF12 MACF1 MORC3 AP4B1	1.40e-08	160	295	12	31678930
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	CPAMD8 CACNA2D2 RPS6KA2 SPTB ADGRV1 ITGB1 HNRNPU PHKB KIDINS220 TECPR2 PROM2 FUBP1 NUP210 ALDH3B2 UTRN SMURF2 AGAP1 EP400P1 PSAT1 MAN2B2 LRRN1 JADE2 STXBP5L ARHGEF18 CEP192 SBNO2 ARHGAP6 XPNPEP3 TTC21B NT5C2 CSTF3 ANKRD17 MACF1 LSS IFT122 EIF2AK4	1.86e-08	1489	295	36	28611215
Pubmed	Rewiring of the Human Mitochondrial Interactome during Neuronal Reprogramming Reveals Regulators of the Respirasome and Neurogenesis.	GLRX5 SYNJ2BP MCAM PHB2 ITGAV ITGB1 AK3 HNRNPU RFTN1 P3H1 UTRN CACNA2D1 PYURF OAT LARS2 CYFIP2 NPTN PPP2R1A EEF2 TRAP1 STON2 ELANE LSS EMC2 MX2 ARHGAP19	2.76e-08	859	295	26	31536960
Pubmed	Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.	RHOJ MCAM ITGAV ITGB1 SLC38A2 RFTN1 KIDINS220 DLG2 UTRN AGAP1 SASH1 CYFIP2 NPTN CD22 APPL1 DEPDC1B GAB1	3.05e-08	377	295	17	38117590
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	TDRD15 MCAM ITGB1 DDX3X SLC38A2 KIDINS220 PLD1 FKBP8 PIH1D1 AGAP1 USP36 FAT4 FN1 SYNM MUC16 APOB CEP192 MAPRE1 LIG1 EEF2 UNC5C SNRNP200 PCDH9 GAB1	6.64e-08	777	295	24	35844135
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	SELENOT PHB2 ITGAV ITGB1 DDX3X AK3 HNRNPU XYLT1 RBM25 GBP5 AP1G1 P3H1 LOXL4 SLC27A4 EXOSC9 MAN2B2 FN1 PPIL4 OAT SIN3A CYFIP2 LIG1 NPTN EEF2 TRAP1 XPNPEP3 UNC5C NT5C2 LSS LSM2 MTREX EMC2 CFAP44 SNRNP200	1.00e-07	1451	295	34	30550785
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	PTK2B AP2B1 DLG2 RASAL1 AGAP1 IQSEC3 PCLO PPM1E ARHGEF18 CYFIP2 NPTN PPP2R1A MACF1 APPL1	1.53e-07	281	295	14	28706196
Pubmed	The Tumor Suppressor SASH1 Interacts With the Signal Adaptor CRKL to Inhibit Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.	SYNE2 ASCC2 UTRN SASH1 JADE2 GAB1	1.77e-07	30	295	6	30480076
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	PDCD2 MYO5B ACY3 ADGRV1 GFUS ITGAV ITGB1 DDX3X HSPA12A PROM2 P3H1 OSBPL1A ALDH3B1 MVP UTRN NPHS1 CACNA2D1 PSAT1 VWF FN1 JADE2 ARHGEF12 CYFIP2 EEF2 SLC12A3 ELANE APPL1	2.03e-07	1016	295	27	19056867
Pubmed	Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.	PDCD2 PHB2 DDX3X HNRNPU RBM25 AP2B1 AP1G1 RWDD1 SESN2 FKBP8 GNL1 IPO7 SYNM PPIL4 PAF1 EEF2 YJU2 STON2 CSTF3 MTREX PALLD	2.34e-07	653	295	21	33742100
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	ZNF234 CDH23 ISLR PKD1L2 MAST2 DDX3X DNAJC24 USP36 DOCK3 SEC16B ARHGEF12 MAPRE1 CELSR3 MACF1 PALLD	5.65e-07	361	295	15	26167880
Pubmed	The characterization of the Olf-1/EBF-like HLH transcription factor family: implications in olfactory gene regulation and neuronal development.	EBF2 EBF3 EBF1	6.04e-07	3	295	3	9151732
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	MYO5B SPTB PHB2 HNRNPU PTK2B PHKB HSPA12A KIDINS220 AP2B1 AP1G1 CAMKV SCAPER DLG2 UTRN RASAL1 ARMC8 CACNA2D1 IQSEC3 VWF FN1 PCLO ARHGEF12 KIAA1549 OAT CYFIP2 NPTN PPP2R1A EEF2 THBS4 STON2 MACF1 SNRNP200	6.80e-07	1431	295	32	37142655
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	MCAM ITGAV ITGB1 RFTN1 HSPA12A KIDINS220 UTRN AGAP1 SASH1 DSC3 CYFIP2 UNC5C MACF1 APPL1 DEPDC1B GAB1	7.72e-07	421	295	16	36976175
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	PDE3A LRSAM1 GFUS DCK DDX3X HNRNPU FANCD2 AP2B1 AP1G1 P3H1 FUBP1 PIH1D1 USP48 MVP GNL1 RASAL1 DYNC1I2 PSAT1 IPO7 PAF1 PPP4R3B MAPRE1 LIG1 PPP2R1A GTF2E1 EEF2 TRAP1 NT5C2 MACF1 APPL1 LSM2 SNRNP200	9.71e-07	1455	295	32	22863883
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	RPS6KA2 DCK LYST PTK2B PHKB AP2B1 SCAPER MERTK TAF1L GNL1 UTRN OAT CEP192 SIN3A MAP3K6 CYFIP2 MAPRE1 PPP2R1A ARHGEF40 RNF2 STON2 EIF2AK4 PALLD SOS1	1.13e-06	910	295	24	36736316
Pubmed	Strain background effects and genetic modifiers of hearing in mice.	CDH23 ADGRV1 TUB PCDH15	1.60e-06	11	295	4	16579977
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	MYO5B MAST2 HSPA12A TMEM132A SCAPER KIAA1549 CELSR3 MACF1 SNRNP200	1.81e-06	130	295	9	12421765
Pubmed	Comparative DNA sequence analysis of mouse and human protocadherin gene clusters.	PCDHGB7 PCDHGB3 PCDHGA7 PCDHB7 PCDHAC1 PCDHGA12 PCDHGB4	1.83e-06	68	295	7	11230163
Pubmed	Network organization of the huntingtin proteomic interactome in mammalian brain.	MYO5B RPS6KA2 SPTB ITIH1 DDX3X PTK2B HSPA12A AP2B1 AP1G1 MVP GNL1 DDX4 RASAL1 MAN2B2 IPO7 SASH1 PCLO EEF2 TRAP1	1.85e-06	621	295	19	22794259
Pubmed	The selective regulation of alpha Vbeta 1 integrin expression is based on the hierarchical formation of alpha V-containing heterodimers.	ITGAV ITGB1 FN1	2.40e-06	4	295	3	11997396
Pubmed	Cloning and functional characterization of Roaz, a zinc finger protein that interacts with O/E-1 to regulate gene expression: implications for olfactory neuronal development.	EBF2 EBF3 EBF1	2.40e-06	4	295	3	9151733
Pubmed	Cloning of a novel Olf-1/EBF-like gene, O/E-4, by degenerate oligo-based direct selection.	EBF2 EBF3 EBF1	2.40e-06	4	295	3	12139918
Pubmed	Role for a novel Usher protein complex in hair cell synaptic maturation.	CDH23 ADGRV1 PCDH15	2.40e-06	4	295	3	22363448
Pubmed	Interaction of protocadherin-15 with the scaffold protein whirlin supports its anchoring of hair-bundle lateral links in cochlear hair cells.	CDH23 ADGRV1 PCDH15	2.40e-06	4	295	3	33009420
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	IFT172 DDX3X AP2B1 AP1G1 NUP210 FKBP8 ASCC3 DYNC1I2 RAD21 IPO8 IPO7 SIN3A PPP2R1A EEF2 TRAP1 CSTF3 APPL1 MTREX SNRNP200	2.73e-06	638	295	19	33239621
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	CARD10 HNRNPU FANCD2 HSPA12A FUBP1 USP48 MVP RAD21 IPO7 RAE1 MAGEE2 PPP2R1A TRAP1 RNF2 CSTF3 MACF1 MTREX SNRNP200	2.98e-06	582	295	18	20467437
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	MYO5B IFT172 PHB2 CDH23 ITGAV AP2B1 OSBPL1A AIPL1 PIH1D1 DYNC1I2 AGAP1 ARMC8 EXOSC9 IPO8 EBF3 MAPRE1 PPP2R1A TRAP1 RNF2 DCTN6 XPNPEP3 TTC21B APPL1 IFT122 MORC3 SNRNP200 PCDH9 DEPDC1B ARHGAP19	3.35e-06	1321	295	29	27173435
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ADGRV1 SLC38A2 TECPR2 AGAP1 RAD21 USP36 SASH1 JADE2 KIAA1549 FNDC3A PREPL PPP4R3B CELSR3 ANKRD17 KDM7A EIF2AK4 MTREX	3.40e-06	529	295	17	14621295
Pubmed	MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1.	ITGB1 DDX3X HNRNPU AP2B1 FUBP1 MVP DYNC1I2 IPO7 EEF2 TRAP1	3.92e-06	182	295	10	30711629
Pubmed	Control of a neuronal morphology program by an RNA-binding zinc finger protein, Unkempt.	PHB2 ITGB1 HNRNPU SLC38A2 AP1G1 RAD21 IPO7 SIN3A MAPRE1 EEF2 CSTF3 MTREX	4.04e-06	271	295	12	25737280
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	PDCD2 LRSAM1 PHB2 SRCAP DCK HNRNPU AP2B1 AP1G1 FUBP1 ASCC3 MVP UTRN DYNC1I2 SLC27A4 USP36 IPO7 FN1 RNF31 DSC3 PLEKHG4 PPIL4 PPP2R1A EEF2 ARHGEF40 ANKRD17 MACF1 MTREX SNRNP200 PALLD	5.30e-06	1353	295	29	29467282
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	PDE3A MAST2 FER1L6 DDX3X FAT2 TERT EEF2 MACF1 PPIP5K1 MTREX SNRNP200	5.80e-06	234	295	11	36243803
Pubmed	Formation of whisker-related principal sensory nucleus-based lemniscal pathway requires a paired homeodomain transcription factor, Drg11.	EBF2 EBF3 EBF1	5.97e-06	5	295	3	12917357
Pubmed	Expression patterns of the coe/ebf transcription factor genes during chicken and mouse limb development.	EBF2 EBF3 EBF1	5.97e-06	5	295	3	15261831
Pubmed	Role of the integrin alpha v beta 6 in cell attachment to fibronectin. Heterologous expression of intact and secreted forms of the receptor.	ITGAV ITGB1 FN1	5.97e-06	5	295	3	8120056
Pubmed	Endothelial FN (Fibronectin) Deposition by α5β1 Integrins Drives Atherogenic Inflammation.	ITGAV ITGB1 FN1	5.97e-06	5	295	3	30354234
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	SRCAP DDX3X HNRNPU USP48 RAD21 EXOSC9 SIN3A PAF1 PPP2R1A EEF2 MORC3 SNRNP200 PALLD	6.13e-06	332	295	13	32786267
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	MYO5B SRCAP ITGB1 DDX3X HNRNPU RBM25 FUBP1 SYNE2 NUP210 FKBP8 ASCC3 UTRN CACNA2D1 EXOSC9 IPO7 RAE1 PPP2R1A TRAP1 XPNPEP3 CSTF3 MACF1 MTREX EMC2 SNRNP200	8.37e-06	1024	295	24	24711643
Pubmed	ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold.	MFHAS1 AK9 DDX3X HNRNPU AP2B1 AP1G1 P3H1 FUBP1 LRRC8E IPO7 LARS2 RIT2 PPP2R1A EEF2 MTREX	8.56e-06	451	295	15	36168627
Pubmed	Mapping the Genetic Landscape of Human Cells.	RBM25 ASCC3 EXOSC9 MED10 RAE1 TTI2 CEP192 LARS2 PPP2R1A GTF2E1 CSTF3 MTREX EMC2 SNRNP200 RBFA	8.56e-06	451	295	15	30033366
Pubmed	Ubiquitin-assisted phase separation of dishevelled-2 promotes Wnt signalling.	PHB2 AP2B1 AP1G1 PLD1 FKBP8 ARMC8 PPP2R1A EEF2 STON2	1.04e-05	161	295	9	36398662
Pubmed	Characterization of long cDNA clones from human adult spleen. II. The complete sequences of 81 cDNA clones.	RNF31 JADE2 ARHGEF40 ARHGAP19	1.11e-05	17	295	4	12693554
Pubmed	New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules.	DCK MAST2 HNRNPU AP2B1 FUBP1 ASCC2 DLG2 PLD1 ASCC3 FN1 RAE1 PCLO PPP2R1A FRY ANKRD17	1.14e-05	462	295	15	31138677
Pubmed	Family of Ebf/Olf-1-related genes potentially involved in neuronal differentiation and regional specification in the central nervous system.	EBF2 EBF3 EBF1	1.19e-05	6	295	3	9389446
Pubmed	Differential onset of expression of alpha 7 and beta 1D integrins during mouse heart and skeletal muscle development.	ITGAV ITGB1 VWF	1.19e-05	6	295	3	9686317
Pubmed	A novel fibronectin receptor with an unexpected subunit composition (alpha v beta 1).	ITGAV ITGB1 FN1	1.19e-05	6	295	3	2138612
Pubmed	Fibronectin- and vitronectin-induced microglial activation and matrix metalloproteinase-9 expression is mediated by integrins alpha5beta1 and alphavbeta5.	ITGAV ITGB1 FN1	1.19e-05	6	295	3	17548654
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	PHB2 ITGB1 DDX3X HNRNPU RBM25 KIDINS220 ASCC3 IPO7 DSC3 ARHGEF12 FNDC3A PPP2R1A EEF2 ANKRD17 MACF1 SNRNP200 DEPDC1B PALLD GAB1	1.19e-05	708	295	19	39231216
Pubmed	Quantifying domain-ligand affinities and specificities by high-throughput holdup assay.	SYNJ2BP MAST2 DLG2 LNX2 ARHGEF12	1.29e-05	36	295	5	26053890
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	RGPD1 KIDINS220 ASCC3 UTRN ARHGEF12 CEP192 MACF1 TRAK2 PALLD GAB1	1.32e-05	209	295	10	36779422
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	MAST2 DDX3X HNRNPU AP1G1 FKBP8 SLC27A4 RNF31 SIN3A MAP3K6 SBNO2 AIFM2 ARHGEF40 ANKRD17 IFT122 EIF2AK4 AP4B1 MTREX PALLD	1.34e-05	650	295	18	38777146
Pubmed	SARS-CoV-2 Nsp6 damages Drosophila heart and mouse cardiomyocytes through MGA/MAX complex-mediated increased glycolysis.	ITGB1 TBC1D9 DDX3X HNRNPU FANCD2 P3H1 NUP210 FKBP8 DYNC1I2 SLC27A4 IPO8 IPO7 PPP2R1A EEF2 RNF2 NT5C2 EMC2 SNRNP200	1.54e-05	657	295	18	36180527
Pubmed	Direct and indirect control of mitogen-activated protein kinase pathway-associated components, BRAP/IMP E3 ubiquitin ligase and CRAF/RAF1 kinase, by the deubiquitylating enzyme USP15.	LRSAM1 UHRF2 USP1 USP36 LNX2 RNF2	1.60e-05	63	295	6	23105109
Pubmed	Biochemical characterization of native Usher protein complexes from a vesicular subfraction of tracheal epithelial cells.	CDH23 ADGRV1 PCDH15	2.06e-05	7	295	3	20058854
Pubmed	Integrins are required for the differentiation of visceral endoderm.	ITGAV ITGB1 FN1	2.06e-05	7	295	3	19118216
Pubmed	Constitutive Association of Tie1 and Tie2 with Endothelial Integrins is Functionally Modulated by Angiopoietin-1 and Fibronectin.	ITGAV ITGB1 FN1	2.06e-05	7	295	3	27695111
Pubmed	Ebf factors and MyoD cooperate to regulate muscle relaxation via Atp2a1.	EBF2 EBF3 EBF1	2.06e-05	7	295	3	24786561
Pubmed	Differential effects of the integrins alpha9beta1, alphavbeta3, and alphavbeta6 on cell proliferative responses to tenascin. Roles of the beta subunit extracellular and cytoplasmic domains.	ITGAV ITGB1 FN1	2.06e-05	7	295	3	8798654
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	SPTB MAST2 ITGB1 SYNE2 USP1 UTRN VWF IPO7 FN1 PAF1 PREPL RNF2 MACF1 APPL1 PALLD	2.66e-05	497	295	15	23414517
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	AP2B1 AP1G1 ASCC2 DYNC1I2 RAD21 EXOSC9 IPO7 SIN3A PAF1 INTS10 PPP2R1A TRAP1 CSTF3 LSS MTREX SNRNP200	2.78e-05	560	295	16	35241646
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	MFHAS1 RPS6KA2 CARD10 SRCAP MAST2 LYST TBC1D9 LIME1 PROM2 TMEM132A LRRC56 RGL2 SMURF2 RASAL1 LRRC8E DOCK3 CEP192 LARS2 SBNO2 ARHGEF40 CELSR3 ZFYVE26 KLHL17 TJP3	2.87e-05	1105	295	24	35748872
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	SRCAP TECPR2 DOCK3 SYNM ARHGEF12 PPIP5K1 ZFYVE26	3.10e-05	104	295	7	9205841
Pubmed	Genetic disruptions of O/E2 and O/E3 genes reveal involvement in olfactory receptor neuron projection.	EBF2 EBF3 EBF1	3.28e-05	8	295	3	14993187
Pubmed	Mouse AMACO, a kidney and skin basement membrane associated molecule that mediates RGD-dependent cell attachment.	ITGB1 COL7A1 FN1	3.28e-05	8	295	3	19651211
Pubmed	Microarray-based mutation analysis of 183 Spanish families with Usher syndrome.	CDH23 ADGRV1 PCDH15	3.28e-05	8	295	3	19683999
Pubmed	Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.	SPTB MAST2 HNRNPU SYNE2 ARHGEF12 EEF2 TRAP1 CELSR3 CFAP44	3.42e-05	187	295	9	26460568
Pubmed	Proteomic analysis of integrin-associated complexes identifies RCC2 as a dual regulator of Rac1 and Arf6.	PHB2 ITGAV ITGB1 DDX3X HNRNPU KIDINS220 AP2B1 FUBP1 NUP210 FN1 RAE1 MAPRE1 PPP2R1A EEF2 TRAP1 STON2 MACF1 SNRNP200	4.03e-05	707	295	18	19738201
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	PHB2 CARD10 ITGB1 HNRNPU FANCD2 AP2B1 SYNE2 NUP210 RWDD1 ASCC2 FKBP8 ASCC3 SLC27A4 ARMC8 CACNA2D1 PSAT1 EXOSC9 IPO8 IPO7 JADE2 TTI2 OAT PPP2R1A EEF2 TRAP1 MTREX EMC2 SNRNP200	4.42e-05	1440	295	28	30833792
Pubmed	The splicing factor FUBP1 is required for the efficient splicing of oncogene MDM2 pre-mRNA.	HNRNPU FUBP1 IPO7 EEF2	4.71e-05	24	295	4	24798327
Pubmed	Auditory cortex interneuron development requires cadherins operating hair-cell mechanoelectrical transduction.	CDH23 ADGRV1 PCDH15	4.89e-05	9	295	3	28705869
Pubmed	TULP3 bridges the IFT-A complex and membrane phosphoinositides to promote trafficking of G protein-coupled receptors into primary cilia.	TUB TTC21B IFT122	4.89e-05	9	295	3	20889716
Pubmed	Stasimon/Tmem41b localizes to mitochondria-associated ER membranes and is essential for mouse embryonic development.	PHB2 HNRNPU NUP210 IPO8 IPO7 APOB TRAP1	5.28e-05	113	295	7	30352685
Pubmed	Functional proteomics mapping of a human signaling pathway.	MCAM DDX3X AP1G1 ASCC2 ASCC3 MERTK UHRF2 UTRN SMURF2 VWF FN1 SASH1 PPIL4 ST6GALNAC2 PPP2R1A MACF1	5.28e-05	591	295	16	15231748
Pubmed	Characterization of SARS-CoV-2 proteins reveals Orf6 pathogenicity, subcellular localization, host interactions and attenuation by Selinexor.	ITGB1 DDX3X HNRNPU P3H1 NUP210 DYNC1I2 IPO8 RAE1 PPP2R1A EEF2 NT5C2 EMC2 SNRNP200	5.29e-05	408	295	13	33766124
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	RPS6KA2 MAST2 LYST DDX3X SLC38A2 PTK2B SYNE2 RGL2 UTRN SASH1 CEP192 MAP3K6 ANKRD17 MACF1 MORC3 MTREX DEPDC1B PALLD GAB1 ARHGAP19	5.42e-05	861	295	20	36931259
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	ZNF131 ITGB1 AP2B1 AP1G1 PIH1D1 MOCS2 USP36 DSC3 MAPRE1 LIG1 GTF2E1 TRAP1 CSTF3 MACF1	5.92e-05	472	295	14	38943005
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	DDX3X HNRNPU RBM25 KIDINS220 NUP210 ASCC3 EEF2 ARHGEF40 SNRNP200	6.22e-05	202	295	9	24639526
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	PHB2 FANCD2 SLC38A2 KIDINS220 AP1G1 P3H1 NUP210 FKBP8 ASCC3 SLC27A4 IPO7 RAE1 TTI2 FNDC3A NPTN PPP2R1A ARHGEF40 CSTF3 ANKRD17 LSS EMC2	6.34e-05	942	295	21	31073040
Pubmed	Oct4 links multiple epigenetic pathways to the pluripotency network.	HNRNPU TAF1L DDX4 RAD21 PAF1 GTF2E1 EEF2 RNF2 ANKRD17	6.46e-05	203	295	9	22083510
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	PRDM2 HNRNPU P3H1 ZFR2 UTRN ITPRIPL1 FAT4 FN1 PCDHGB3 PCLO TTI2 NTMT1 MAGEE2 SPATC1 FRY THBS4 CFAP44 SNRNP200	6.72e-05	736	295	18	29676528
Pubmed	Massively parallel DNA sequencing facilitates diagnosis of patients with Usher syndrome type 1.	CDH23 ADGRV1 PCDH15	6.94e-05	10	295	3	24618850
Pubmed	Stereocilia defects in the sensory hair cells of the inner ear in mice deficient in integrin alpha8beta1.	ITGAV ITGB1 FN1	6.94e-05	10	295	3	10742111
Pubmed	The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence.	ITGAV ITGB1 FN1	6.94e-05	10	295	3	7690138
Pubmed	The WD40-domain containing protein CORO2B is specifically enriched in glomerular podocytes and regulates the ventral actin cytoskeleton.	ITGAV ITGB1 NPHS1	6.94e-05	10	295	3	29162887
Pubmed	Usher protein functions in hair cells and photoreceptors.	CDH23 ADGRV1 PCDH15	6.94e-05	10	295	3	24239741
Pubmed	Integrin-Mediated Focal Anchorage Drives Epithelial Zippering during Mouse Neural Tube Closure.	ITGAV ITGB1 FN1	6.94e-05	10	295	3	32049039
Pubmed	AlphaV- and beta1-integrin subunits are commonly expressed in malignant effusions from ovarian carcinoma patients.	ITGAV ITGB1	7.17e-05	2	295	2	12893184
Pubmed	Type VII collagen specifically binds fibronectin via a unique subdomain within the collagenous triple helix.	COL7A1 FN1	7.17e-05	2	295	2	7963647
Interaction	AGAP2 interactions	PTK2B AP2B1 DLG2 RASAL1 IQSEC3 LNX2 PCLO PPM1E ARHGEF18 CYFIP2 NPTN PPP2R1A MACF1 APPL1	2.20e-06	210	289	14	int:AGAP2
Interaction	RHOA interactions	PDCD2 PDE3A RHOJ MCAM AK9 ITGAV ITGB1 FANCD2 SLC38A2 PTPN2 HSPA12A KIDINS220 SYNE2 NUP210 PLD1 FKBP8 USP48 UTRN SMURF2 AGAP1 FAT4 DSC3 PLEKHG4 ARHGEF12 KIAA1549 ARHGEF18 FNDC3A CYFIP2 TRAP1 STON2 MACF1 TYW1 EMC2 DEPDC1B GAB1 MX2 ARHGAP19 KLHL17	3.73e-06	1199	289	38	int:RHOA
Interaction	RAC1 interactions	MYO5B RHOJ MCAM PHB2 ITGAV ITGB1 DDX3X FANCD2 SLC38A2 HSPA12A KIDINS220 AP2B1 PLD1 USP48 RGL2 UTRN SMURF2 AGAP1 DOCK3 PSAT1 VWF IPO8 IPO7 FN1 PLEKHG4 KIAA1549 CYFIP2 EEF2 ARHGEF40 STON2 MACF1 EMC2 DEPDC1B GAB1 SOS1	4.09e-06	1063	289	35	int:RAC1
Interaction	KPNB1 interactions	RGPD1 ITGB1 LYST HNRNPU FANCD2 PTPN2 NUP210 PIH1D1 USP48 USP1 GNL1 RAD21 USP36 IPO8 IPO7 FN1 RAE1 FNDC3A CEP192 MAPRE1 NT5C2 SNRNP200	1.35e-05	544	289	22	int:KPNB1
Interaction	BIN1 interactions	MCAM SYNE2 PLD1 USP48 IPO8 SYNM LIG1 EEF2 APPL1 SOS1	1.72e-05	129	289	10	int:BIN1
Interaction	LGALS1 interactions	ZNF131 MCAM PHB2 ITGAV ITGB1 FANCD2 FUBP1 MERTK PIH1D1 FAT4 FN1 RAE1 KIAA1549 MUC16 TRAP1 PCDH9	2.64e-05	332	289	16	int:LGALS1
Cytoband	5q31	PCDHGB7 PCDHGB3 PCDHGA7 PCDHB7 PCDHAC1 PCDHGA12 PCDHGB4	1.02e-05	115	295	7	5q31
GeneFamily	Clustered protocadherins	PCDHGB7 PCDHGB3 PCDHGA7 PCDHB7 PCDHAC1 PCDHGA12 PCDHGB4	5.63e-06	64	195	7	20
GeneFamily	Cadherin related	CDH23 FAT2 PCDH15 FAT4	2.80e-05	17	195	4	24
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	IGFN1 ISLR MERTK SIGLEC12 LRRN1 NPTN UNC5C PALLD ALPK2	6.40e-05	161	195	9	593
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	SPTB PLD1 RASAL1 AGAP1 PLEKHG4 VEPH1 ARHGEF18 APPL1 GAB1 SOS1	8.26e-05	206	195	10	682
GeneFamily	X-linked mental retardation\|RNA helicases	ASCC3 MTREX SNRNP200	1.91e-04	11	195	3	1168
GeneFamily	CTAGE family	CTAGE4 CTAGE9 CTAGE8	5.11e-04	15	195	3	907
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	PLEKHG4 ARHGEF12 ARHGEF18 ARHGEF40 SOS1	7.27e-04	66	195	5	722
GeneFamily	C2-set domain containing\|Immunoglobulin like domain containing\|Scavenger receptors	MCAM SIGLEC12 NPHS1 CD22	8.85e-04	40	195	4	592
GeneFamily	PDZ domain containing	SYNJ2BP MAST2 DLG2 LNX2 PCLO ARHGEF12 TJP3	1.32e-03	152	195	7	1220
GeneFamily	SEC14 family\|PRELI domain containing	SEC14L1 SEC14L5	1.69e-03	6	195	2	1063
GeneFamily	SEC14 family\|PRELI domain containing	SEC14L1 SEC14L5	1.69e-03	6	195	2	1295
GeneFamily	Fibronectin type III domain containing	IGFN1 FNDC1 MERTK NPHS1 COL7A1 FN1 FNDC3A	1.78e-03	160	195	7	555
GeneFamily	Intraflagellar transport proteins\|Tetratricopeptide repeat domain containing	IFT172 TTC21B IFT122	2.12e-03	24	195	3	615
GeneFamily	Calcium voltage-gated channel subunits\|Membrane associated guanylate kinases	CARD10 DLG2 TJP3	2.68e-03	26	195	3	904
GeneFamily	Adenylate kinases	AK9 AK3	3.96e-03	9	195	2	356
Coexpression	GSE32423_IL7_VS_IL7_IL4_NAIVE_CD8_TCELL_DN	ZNF131 LYST PHKB RBM25 LOXL4 DLG2 ALDH3B1 INTS6L CYFIP2 PPP4R3B LSS MTREX	2.98e-06	200	294	12	M5096
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000	MYO5B ADGRV1 TUB DDX3X HNRNPU XYLT1 RBM25 RIMKLB TRPM5 KCNJ2 ZFR2 SYNE2 NUP210 SCAPER PCDH11X PLD1 USP1 RASAL1 SLC27A4 CACNA2D1 IQSEC3 LNX2 LRRN1 SYNM STXBP5L PCLO PPM1E LARS2 CYFIP2 AIFM2 STON2 LSS PCDH9 FILIP1L	6.15e-07	983	289	34	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	ZKSCAN8 SRCAP PRDM2 FUBP1 SYNE2 NUP210 DNAJC24 RAD21 EXOSC9 LRRN1 PCLO PPM1E PPIL4 ARHGEF12 FNDC3A PAF1 LARS2 CYFIP2 LIG1 RNF2 MACF1 EIF2AK4 SNRNP200 SOS1	2.36e-06	595	289	24	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000	ADGRV1 ITGAV TUB FANCD2 XYLT1 PTK2B FNDC1 RBM25 STYX PROM2 KCNJ2 SCAPER PCDH15 DLG2 PIH1D1 RASAL1 IQSEC3 LNX2 PLEKHG4 SYNM PCLO VEPH1 E2F2 LARS2 MAP3K6 CYFIP2 AIFM2 CATSPER4 MACF1 FILIP1L	3.04e-05	979	289	30	Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	MYO5B DDX3X HNRNPU RIMKLB SYNE2 NUP210 SLC27A4 LRRN1 STXBP5L PCLO PPM1E CYFIP2 AIFM2 LSS PCDH9	4.76e-05	328	289	15	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5	ZKSCAN8 HNRNPU PTPN2 SYNE2 DNAJC24 RAD21 CACNA2D1 EXOSC9 LRRN1 STXBP5L ARHGEF12 FNDC3A LIG1 GTF2E1 AIFM2 RNF2 MACF1 EIF2AK4 MTREX EMC2 PCDH9 SOS1	5.54e-05	629	289	22	Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5
CoexpressionAtlas	gudmap_RNAseq_p2_Glomerlular Endothelial_2500_K4	PDE3A RHOJ ACY3 MCAM ITGB1 RFTN1 HSPA12A GBP5 MERTK ALDH3B1 MVP JADE2 ARHGEF12 EBF1 MAP3K6 FRY	1.03e-04	392	289	16	gudmap_RNAseq_p2_Glomerlular Endothelial_2500_K4
CoexpressionAtlas	FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4	ZKSCAN8 PTPN2 SYNE2 DNAJC24 UTRN ARHGEF12 FNDC3A GTF2E1 MACF1 EIF2AK4 SOS1	1.12e-04	203	289	11	Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PDE3A MCAM EBF2 XYLT1 RFTN1 AGAP1 CACNA2D1 SYNM EBF1 CDH19 ARHGAP6 UNC5C	5.15e-09	188	295	12	ee151792c7ac9afe820f1a281c6dab383799f358
ToppCell	COVID-19-Heart\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PDE3A SPTB EBF2 CACNA2D1 SYNM EBF3 EBF1 CDH19 FRY PCDH9 PALLD FILIP1L	5.80e-09	190	295	12	918ad5037881212008f9f69d5df5da91fd01422c
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PDE3A SPTB MCAM RFTN1 AGAP1 CACNA2D1 SYNM EBF1 CDH19 ARHGAP6 UNC5C	3.15e-08	178	295	11	185b44700f06ec58b3c09c80520502166c965fd6
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PDE3A MCAM EBF2 XYLT1 RFTN1 CACNA2D1 SYNM EBF1 CDH19 ARHGAP6 UNC5C	3.74e-08	181	295	11	451b87ac95154bb80018b8dd245b4a6389d81411
ToppCell	Adult-Mesenchymal-pericyte_cell\|Adult / Lineage, Cell type, age group and donor	PDE3A SPTB MCAM XYLT1 RFTN1 COL7A1 SYNM EBF1 CDH19 ARHGAP6 UNC5C	5.23e-08	187	295	11	62759efb660179402fb574ce5701c89a2e17bcfe
ToppCell	COVID-19-kidney-AQP1+SLC14A1+EC\|kidney / Disease (COVID-19 only), tissue and cell type	PDE3A RHOJ RPS6KA2 MCAM KCNJ2 UTRN SEC14L1 FAT4 VWF FN1 EBF1	6.15e-08	190	295	11	1519f34d31fe0817184c5865a0bc9f0cb479b1a4
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGB1 DDX3X HNRNPU SLC38A2 MVP UTRN IPO7 ARHGEF12 LARS2 NPTN EEF2	8.44e-08	196	295	11	151f1a29a91f8b234e9b6ed062666357a2f69128
ToppCell	Parenchymal-NucSeq-Stromal-Pericyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PDE3A MCAM EBF2 XYLT1 RFTN1 SYNM EBF1 CDH19 ARHGAP6 UNC5C FILIP1L	8.89e-08	197	295	11	41dd312f46a2b983c8d864adeb6970c0ca4a8048
ToppCell	Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PDE3A MCAM EBF2 XYLT1 RFTN1 SYNM EBF1 CDH19 ARHGAP6 UNC5C FILIP1L	8.89e-08	197	295	11	f66945f9007d59d4208849c7fd727f8519713fbc
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	RPS6KA2 ITGB1 RGL2 SMURF2 SEC14L1 C1orf54 VWF FN1 ARHGEF12 MACF1 FILIP1L	1.04e-07	200	295	11	2d07237022b409c4fac6fcf99b68c8affb3007cd
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A RFTN1 GRIN3A FN1 EBF1 FRY UNC5C ADGRD2 PCDH9 ARHGAP19	1.28e-07	161	295	10	1b805f77790aeb8a71b08bfac2fe2eed7343258f
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A RHOJ RFTN1 GRIN3A FN1 EBF1 UNC5C ADGRD2 PCDH9 ARHGAP19	2.37e-07	172	295	10	08a3fe536b1b064c5ee7779bc2b1115a5963a26b
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A RHOJ RFTN1 GRIN3A FN1 EBF1 UNC5C ADGRD2 PCDH9 ARHGAP19	2.37e-07	172	295	10	553701349444eb366df3c11f54bb093434f153c6
ToppCell	LPS-IL1RA+antiTNF-Hematopoietic_Meg-Ery\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GLRX5 SPTB AK9 DCK ASCC2 FKBP8 E2F2 TRIM10 NPTN TRAK2	3.43e-07	179	295	10	7329b45376a9e9a4fe34d4aa0b33af6dda0a8e3b
ToppCell	LPS-IL1RA+antiTNF-Hematopoietic_Meg-Ery-Erythroid\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GLRX5 SPTB AK9 DCK ASCC2 FKBP8 E2F2 TRIM10 NPTN TRAK2	3.43e-07	179	295	10	6e4740f99f66d3e9348fa5057cf1030454819aa8
ToppCell	LPS-IL1RA+antiTNF-Hematopoietic_Meg-Ery-Erythroid-Erythroid\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GLRX5 SPTB AK9 DCK ASCC2 FKBP8 E2F2 TRIM10 NPTN TRAK2	3.43e-07	179	295	10	ee60ac43fb62c09967a26bbcf9306ac5ea2bdc1e
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	RHOJ EBF2 VWF FN1 EBF3 EBF1 CDH19 THBS4 UNC5C FILIP1L	4.00e-07	182	295	10	fbd5e332df73bf7141c822fa67b76367dc962017
ToppCell	Adult-Mesenchymal-pericyte_cell-D122\|Adult / Lineage, Cell type, age group and donor	PDE3A SPTB MCAM XYLT1 COL7A1 SYNM EBF1 CDH19 ARHGAP6 UNC5C	4.20e-07	183	295	10	fc31a43a637423cb3bb9aa184a3a889a0b9aaea6
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGFN1 COL22A1 ADGRV1 PKD1L2 PCDH11X PCDH15 FAT4 STXBP5L PCLO APOB	4.42e-07	184	295	10	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGFN1 COL22A1 ADGRV1 PKD1L2 PCDH11X PCDH15 FAT4 STXBP5L PCLO APOB	4.42e-07	184	295	10	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4\|TCGA-Pancreas / Sample_Type by Project: Shred V9	ATP8B4 EBF2 DLG2 UTRN CACNA2D1 FAT4 SASH1 PCDHGA12 APPL1 PCDH9	4.42e-07	184	295	10	67164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGFN1 COL22A1 ADGRV1 PKD1L2 PCDH11X PCDH15 FAT4 STXBP5L PCLO APOB	4.42e-07	184	295	10	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	LPS_only-Hematopoietic_Meg-Ery-Erythroid-Erythroid\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GLRX5 SPTB AK9 DCK ASCC2 FKBP8 E2F2 TRIM10 NPTN TRAK2	4.88e-07	186	295	10	e5014443e9d6e25943308483e20d48b776ae5373
ToppCell	LPS_only-Hematopoietic_Meg-Ery-Erythroid\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GLRX5 SPTB AK9 DCK ASCC2 FKBP8 E2F2 TRIM10 NPTN TRAK2	4.88e-07	186	295	10	affc246a1091e44dc85a5e237c778a7541d5a2b4
ToppCell	LPS_only-Hematopoietic_Meg-Ery\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GLRX5 SPTB AK9 DCK ASCC2 FKBP8 E2F2 TRIM10 NPTN TRAK2	4.88e-07	186	295	10	40d1e15402fdfb3b5ae850a2070cd4b68fda3159
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D175\|Adult / Lineage, Cell type, age group and donor	TRABD2B IGFN1 RHOJ CDH23 PCDH15 CACNA2D1 FN1 PRICKLE1 ARHGAP6 UNC5C	5.13e-07	187	295	10	e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f
ToppCell	COPD-Stromal-Pericyte\|Stromal / Disease state, Lineage and Cell class	PDE3A RPS6KA2 MCAM EBF2 RFTN1 MERTK AGAP1 EXOSC9 SASH1 CDH19	5.13e-07	187	295	10	406ecd1dabb3ed8d871aef159f7bd1e383434953
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MFHAS1 ADGRV1 CA10 AK3 DOCK3 CYFIP2 ARHGAP6 SLC12A3 PCDH9 DEPDC1B	5.65e-07	189	295	10	f51cdc9a47371cab8ed9ae63a6f14da07ede446c
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PDE3A MCAM EBF2 RFTN1 AGAP1 SYNM EBF1 CDH19 ARHGAP6 UNC5C	5.93e-07	190	295	10	4eb92aef1ee868f4537483d19014d947b7684612
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PDE3A MCAM EBF2 RFTN1 AGAP1 SYNM EBF1 CDH19 ARHGAP6 UNC5C	5.93e-07	190	295	10	7be4341e2909101d756f14031c21e705eb45e69a
ToppCell	nucseq-Mesenchymal-Myocytic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PDE3A MCAM ISLR EBF2 FNDC1 COL7A1 SYNM EBF1 CDH19 UNC5C	7.18e-07	194	295	10	2d66091097e106c7bee22e5281f50724700bdf8d
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RHOJ RPS6KA2 KCNJ2 UTRN NOS3 SEC14L1 FAT4 VWF EBF3 EBF1	7.18e-07	194	295	10	a429d22c8c9d0fd3bfa9f877a6364cecad68db30
ToppCell	COVID-19-lung-Pericytes/_Smooth_Muscle\|lung / Disease (COVID-19 only), tissue and cell type	PDE3A MCAM EBF2 CACNA2D1 SYNM EBF1 CDH19 FRY UNC5C FILIP1L	7.18e-07	194	295	10	5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RHOJ DDX3X HNRNPU MVP IPO7 ARHGEF12 OAT LARS2 NPTN EEF2	7.88e-07	196	295	10	66d76249bd2770cdddff2c1fe59a016e95da2124
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RHOJ DDX3X HNRNPU MVP IPO7 ARHGEF12 OAT LARS2 NPTN EEF2	7.88e-07	196	295	10	9bd4c146fc7555e32adfa393b3a07846eb826d25
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PDE3A TRABD2B MCAM FN1 SYNM EBF1 ARHGAP6 FRY UNC5C PALLD	8.25e-07	197	295	10	bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052
ToppCell	LPS_anti-TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SPTB AK9 ASCC2 FKBP8 E2F2 TRIM10 NPTN THBS4 SLC12A3 TRAK2	9.05e-07	199	295	10	565404c155dfac57c020a8f2d09cbf756da20ffd
ToppCell	facs-Tongue-nan-3m-Epithelial-nan\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGB1 DDX3X HNRNPU SLC38A2 IPO7 DSC3 ARHGEF12 OAT NPTN EEF2	9.05e-07	199	295	10	8d50e1ee58710d896c0204937331d9f4dcd38de0
ToppCell	(02)_MMP9/10+\|World / shred by cell type by condition	COL22A1 ITGAV ITGB1 SLC38A2 COL7A1 PSAT1 FN1 ARHGEF40 PALLD FILIP1L	9.05e-07	199	295	10	3f78eddeaa67d3b767aa38de765632166b09a4f0
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A KCNJ2 PLD1 FN1 RNF31 SYNM PCDHB7 EBF1 UNC5C	1.54e-06	164	295	9	43630a448f4369fa9e4e3eccdf3b9f29cec16c39
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A RHOJ RFTN1 KCNJ2 GRIN3A EBF1 UNC5C PCDH9 PALLD	1.54e-06	164	295	9	b6df1e67a5ce5f2d86f4e1420f4ee931f760bf4d
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A KCNJ2 PLD1 FN1 RNF31 SYNM PCDHB7 EBF1 UNC5C	1.54e-06	164	295	9	108fbecb56d69a675d6ce6e826a873ae528f2fd7
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A KCNJ2 PLD1 FN1 RNF31 SYNM PCDHB7 EBF1 UNC5C	1.54e-06	164	295	9	46208f18325976c89f572f6627aea0582142b92d
ToppCell	5'-Adult-LymphNode-Hematopoietic-Plasma_cells-IgG_plasma_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TDRD15 NUGGC TBC1D9 LIME1 PTPN2 SEPTIN14 SEC14L1 SBNO2 GAB1	1.89e-06	168	295	9	f5a18123f84c62211d9279e9c41e90122e4c4895
ToppCell	Control-Fibroblasts-Pericytes\|Control / group, cell type (main and fine annotations)	PDE3A MCAM EBF2 SLC38A2 CACNA2D1 EBF1 CDH19 ARHGAP6 UNC5C	2.18e-06	171	295	9	080003f698f867935c2bfc55d241d3650f45a0ab
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRABD2B CA10 TBC1D9 OPTC AGAP1 ARHGAP6 SLC12A3 UNC5C DEPDC1B	2.40e-06	173	295	9	4bc6d93716f093b460c8b047199db8cab5fea720
ToppCell	5'-Adult-LymphNode-Hematopoietic-Plasma_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TDRD15 NUGGC LIME1 PTPN2 SEPTIN14 SEC14L1 SBNO2 EIF2AK4 GAB1	2.64e-06	175	295	9	6a093c74a6f3daeff07759d6eec542fc5c709149
ToppCell	Control-B_cells-Plasma_cells\|Control / group, cell type (main and fine annotations)	NUGGC TBC1D9 MERTK USP48 SEC14L1 PSAT1 FNDC3A EIF2AK4 GAB1	2.64e-06	175	295	9	fb23858cfce71509cafbe0d9728e678012ff2962
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RHOJ RPS6KA2 PCDH11X UTRN NOS3 FAT4 VWF FN1 EBF1	3.03e-06	178	295	9	5f779a66aa42d1d8e8af17b4a08d5dcc733efd4c
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRV1 CA10 AK3 PROM2 PPM1E CYFIP2 SPATC1 ARHGAP6 PCDH9	3.33e-06	180	295	9	a17dbe03597b81e7a1fe2bf2d23e59e55c615a2a
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRV1 CA10 AK3 PROM2 PPM1E CYFIP2 SPATC1 ARHGAP6 PCDH9	3.33e-06	180	295	9	eee71184ebed2694d3e60f579a44b3cf7dd2cd35
ToppCell	3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8\|blood / Manually curated celltypes from each tissue	TMOD4 FNDC1 RBM25 SYNE2 LOXL4 UTRN PPM1E MACF1	3.35e-06	135	295	8	ae2d3a42e567b5bade304c0caa497eb725be3565
ToppCell	droplet-Spleen-nan-18m\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LYST DDX3X HNRNPU EBF1 EEF2 CD22 RASGEF1B MACF1 FILIP1L	3.64e-06	182	295	9	eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c
ToppCell	COVID-19_Severe-RBC\|COVID-19_Severe / disease group, cell group and cell class	GLRX5 SPTB GFUS ASCC2 FKBP8 ARHGEF12 E2F2 TRIM10 TRAK2	3.98e-06	184	295	9	bb58244194ffb5558fbe85c5f856888210dcb1e8
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE3A RPS6KA2 MCAM RFTN1 HSPA12A EBF1 CDH19 ARHGAP6 FILIP1L	3.98e-06	184	295	9	327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b
ToppCell	droplet-Kidney-KIDNEY-30m-Epithelial-Pecam____Kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RHOJ MCAM KCNJ2 NOS3 FAT4 VWF FN1 MAP3K6 PCDH9	4.16e-06	185	295	9	f98af3146ec2f44c30d31a662fb9c4fa3ca4f706
ToppCell	COVID-19-Heart-Fib_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	EBF2 CACNA2D1 FN1 PRICKLE1 EBF3 EBF1 CDH19 UNC5C PCDH9	4.16e-06	185	295	9	8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CA10 XYLT1 PTK2B RASAL1 CACNA2D1 PRICKLE1 STXBP5L RIT2 SEC14L5	4.35e-06	186	295	9	84ba666237c18189d7e7556bd92dd953af733c00
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PDE3A EBF2 XYLT1 AGAP1 SYNM EBF1 CDH19 ARHGAP6 UNC5C	4.54e-06	187	295	9	86250acf088ec0c4800a0dfa031b0d4f7e52c342
ToppCell	COVID-19-Fibroblasts-Airway_smooth_muscle\|COVID-19 / group, cell type (main and fine annotations)	PDE3A MCAM DLG2 CACNA2D1 FN1 EBF1 FRY UNC5C PALLD	4.54e-06	187	295	9	464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE3A MCAM FNDC1 DOCK3 CACNA2D1 EBF1 CDH19 PALLD FILIP1L	4.95e-06	189	295	9	7ab1cfc1657277858339f7258a0c4ae9cb42fdf8
ToppCell	facs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FNDC1 MERTK DDX4 PRICKLE1 KIAA1549 PCDHAC1 MAP3K6 ARHGAP6 FRY	4.95e-06	189	295	9	09dd2b3d89416192e84abe302a6237b8f3fdcb6e
ToppCell	Mesenchymal-pericyte_cell\|World / Lineage, Cell type, age group and donor	PDE3A MCAM RFTN1 AGAP1 SYNM EBF1 CDH19 ARHGAP6 UNC5C	4.95e-06	189	295	9	d7ed96add29f219183c802895fbff519b627f635
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	PDE3A SLC38A2 PCDH15 CACNA2D1 FN1 EBF1 ARHGAP6 UNC5C PALLD	5.17e-06	190	295	9	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	COVID-19-Heart-EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	CPAMD8 MCAM EBF2 RFTN1 SYNE2 UTRN SEC14L1 VWF EBF1	5.17e-06	190	295	9	a21653bfb7bafbc273f94fa7c13bfb48cf8fd562
ToppCell	severe_COVID-19-RBC\|severe_COVID-19 / disease group, cell group and cell class (v2)	GLRX5 SPTB PROM2 ASCC2 FKBP8 ARHGEF12 E2F2 TRIM10 TRAK2	5.17e-06	190	295	9	3a5723c2daf58c1932edd70910db4b8b30f63f42
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MFHAS1 ADGRV1 CA10 RASAL1 DOCK3 COL7A1 SASH1 ARHGAP6 PCDH9	5.39e-06	191	295	9	2fa1b9e76a0ed2d2f0de74349e266cf4a5f51aad
ToppCell	T_cells-CD56_bright_CD16-_NK_cells\|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis	ATP8B4 RPS6KA2 CARD10 SIGLEC12 ABCB5 KIAA1549 UNC5C PCDH9 GAB1	5.87e-06	193	295	9	826457e2aafdb61ead8a0a44d8cf9088d310684b
ToppCell	Healthy-B_cell\|World / disease group, cell group and cell class	ABCB4 PROM2 SESN2 JADE2 EBF1 SPATC1 CD22 PCDH9	5.99e-06	146	295	8	588359d3df6ad7090b7fa6c7f8d29cc1717e7f4f
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A FNDC1 UTRN FN1 EBF1 FRY UNC5C PALLD FILIP1L	6.12e-06	194	295	9	ebb038f94f49f5c655578d1b018676e10c6b7e3c
ToppCell	LV-09._Endothelium_I\|World / Chamber and Cluster_Paper	CPAMD8 CARD10 RFTN1 SYNE2 UTRN SEC14L1 VWF KIAA1549 MAP3K6	6.38e-06	195	295	9	19e0a6c3eae1615aaa39767300acd937dfcb2a7f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A XYLT1 RFTN1 UTRN FN1 EBF1 FRY PALLD FILIP1L	6.64e-06	196	295	9	b8759e6231e0254797d6c30930407b79440c57bb
ToppCell	Tracheal-10x3prime_v2-Epithelial-Epi_airway_neuro-secretory\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	IGFN1 CACNA2D2 DLG2 DDX4 RASAL1 PCDHGB7 PCDHGA7 PCLO AP4B1	6.92e-06	197	295	9	ff4df77117165b6b25315e29b0722cc136eba607
ToppCell	COPD-Endothelial-VE_Capillary_B\|Endothelial / Disease state, Lineage and Cell class	MCAM PCDH15 SMURF2 SEC14L1 C1orf54 VWF KIAA1549 ARHGAP6 LSS	6.92e-06	197	295	9	30dbc05ea66892d2e18ff375ffa86d1db7bc4083
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYO5B ADGRV1 SYNE2 SCAPER PCDH11X UTRN VEPH1 CATSPER4 TJP3	6.92e-06	197	295	9	3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PDE3A TRABD2B MCAM GJD4 EBF2 KLHL34 SYNM EBF1 FILIP1L	7.21e-06	198	295	9	f261a37dd07976548b897af86df1d1a0dc069889
ToppCell	Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PDE3A MCAM CA10 DOCK3 FN1 EBF1 TERT UNC5C PALLD	7.21e-06	198	295	9	d1827e3707b929e3a3562989a0c11537d344e164
ToppCell	Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PDE3A TRABD2B MCAM XYLT1 FN1 SYNM EBF1 ARHGAP6 UNC5C	7.51e-06	199	295	9	b1753474152b82a0b811b9878c890a359e14919a
ToppCell	Bronchial-NucSeq-Stromal-Pericyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PDE3A SPTB MCAM AIPL1 SYNM EBF1 CDH19 ARHGAP6 UNC5C	7.51e-06	199	295	9	854628ce91068093c14bd4d45ba38c41469f3549
ToppCell	LPS_anti-TNF-Hematopoietic_Erythro-Megakary\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SPTB AK9 FKBP8 E2F2 TRIM10 NPTN THBS4 SLC12A3 TRAK2	7.51e-06	199	295	9	6c174dbcc25b980f10a3d1dfe39e613acac73bb6
ToppCell	LPS_anti-TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SPTB AK9 FKBP8 E2F2 TRIM10 NPTN THBS4 SLC12A3 TRAK2	7.51e-06	199	295	9	284ee9632413f6404fc0b0c7c393ad813db834f2
ToppCell	LPS_IL1RA-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	RPS6KA2 KIDINS220 SYNE2 RGL2 SEC14L1 VWF SASH1 ARHGEF12 MACF1	7.82e-06	200	295	9	5c092b2ecc081b5d04476c56333c338cd89ab984
ToppCell	Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CPAMD8 PDE3A TRABD2B XYLT1 FN1 CDH19 FRY UNC5C PCDH9	7.82e-06	200	295	9	f5bd0b30e478dac09f68c46b0781f5f2e7e3c693
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	DDX3X PRDM2 HNRNPU RBM25 SYNE2 UTRN RASGEF1B MACF1 MX2	7.82e-06	200	295	9	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Bronchial-NucSeq-Stromal-Chondrocytic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CPAMD8 PDE3A TRABD2B XYLT1 FN1 EBF3 CDH19 FRY UNC5C	7.82e-06	200	295	9	b7b9441fa7ab0d43741a2ebd5ec1a48d537c6d47
ToppCell	Tracheal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CPAMD8 PDE3A TRABD2B DLG2 FAT4 FN1 EBF3 EBF1 PCDH9	7.82e-06	200	295	9	c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGB1 HNRNPU SLC38A2 PSAT1 SASH1 LRRN1 LARS2 PCDH9 GAB1	7.82e-06	200	295	9	f0c338877e39226a90c4effe12f6501d33542a73
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	RPS6KA2 RGL2 NOS3 SEC14L1 C1orf54 FAT4 VWF SASH1 ARHGEF12	7.82e-06	200	295	9	b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a
ToppCell	Neuronal-Excitatory\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CA10 XYLT1 PTK2B RFTN1 CACNA2D1 PRICKLE1 STXBP5L PCDH9 SEC14L5	7.82e-06	200	295	9	4409065bc7aa995354c71e0f9d6f3726cf393d6b
ToppCell	LPS_only-Endothelial-Endothelial-Artery\|LPS_only / Treatment groups by lineage, cell group, cell type	RPS6KA2 SYNE2 MERTK NOS3 VWF FN1 FRY PALLD FILIP1L	7.82e-06	200	295	9	b17eb1587ca86c3d40515128a00a8d8fd787fccf
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Artery\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PDE3A RPS6KA2 SYNE2 MERTK NOS3 VWF FN1 PALLD FILIP1L	7.82e-06	200	295	9	b1ff8d61b567f85006d6d20093f9c803b6d34674
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	RPS6KA2 ITGB1 SYNE2 RGL2 C1orf54 VWF SASH1 ARHGEF12 MACF1	7.82e-06	200	295	9	4bb609a284d4e6066f17470a1736076aa4a1f84c
ToppCell	Bronchial-NucSeq-Stromal-Chondrocytic-Chondrocyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CPAMD8 PDE3A TRABD2B XYLT1 FN1 EBF3 CDH19 FRY UNC5C	7.82e-06	200	295	9	7c673ad0ea503ebd196579684d25d5f9e6a41030
ToppCell	LPS_IL1RA-Endothelial-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	RPS6KA2 KIDINS220 SYNE2 RGL2 SEC14L1 VWF SASH1 ARHGEF12 MACF1	7.82e-06	200	295	9	72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5
ToppCell	Tracheal-NucSeq-Stromal-Chondrocytic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CPAMD8 PDE3A TRABD2B XYLT1 FN1 CDH19 FRY UNC5C PCDH9	7.82e-06	200	295	9	b5a54b9baf79aea01f76a161f0a39bbe87eb4945
ToppCell	LPS_only-Endothelial-Endothelial-Gen_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	RPS6KA2 ITGB1 SEC14L1 C1orf54 FAT4 VWF SASH1 ARHGEF12 MACF1	7.82e-06	200	295	9	eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PDE3A MCAM EBF2 FNDC1 SYNM EBF1 ARHGAP6 FRY PALLD	7.82e-06	200	295	9	a66449b22b39dd6987fc2c3ed160d24564234ced
ToppCell	LPS_only-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	RPS6KA2 ITGB1 SYNE2 RGL2 C1orf54 VWF SASH1 ARHGEF12 MACF1	7.82e-06	200	295	9	81e76508c9050d533853d5fd2f3097b27613d836
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SYNE2 UTRN NOS3 SEC14L1 C1orf54 FAT4 VWF ARHGEF12 MACF1	7.82e-06	200	295	9	a2b9d1cd291d17abddc3ee2e242121412c864b8b
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated\|COVID-19_Mild / Disease, condition lineage and cell class	SRCAP GBP5 SYNE2 UTRN FAT4 ARHGEF12 CYFIP2 MACF1 PALLD	7.82e-06	200	295	9	2281debd86e5d92e8fe0397aec9ef670800f7471
Drug	Grgds	ITGAV ITGB1 PTK2B VWF FN1 FNDC3A NPTN THBS4 PALLD	1.09e-06	83	289	9	CID000123811
Drug	indole alkaloid	DCK LYST TBC1D9 ABCB4 PTK2B MERTK MVP CACNA2D1 ABCB5 TERT LIG1 TRAP1 MX2 SOS1	3.16e-06	244	289	14	CID000005978
Drug	Grgd Peptide	ITGAV VWF FN1 FNDC3A	5.03e-06	10	289	4	CID000126679
Disease	Retinitis Pigmentosa	IFT172 TUB SCAPER AIPL1 MERTK KIAA1549 ARHGEF18 SNRNP200	6.79e-06	104	279	8	C0035334
Disease	retinal degeneration (implicated_via_orthology)	IFT172 PROM2 MERTK NOS3 IFT122	1.39e-05	33	279	5	DOID:8466 (implicated_via_orthology)
Disease	Intellectual Disability	DDX3X HNRNPU SCAPER ASCC3 DYNC1I2 IQSEC3 TTI2 SIN3A PREPL PPP2R1A FRY P4HTM NT5C2 MACF1 LSS	2.67e-05	447	279	15	C3714756
Disease	childhood trauma measurement, alcohol consumption measurement	DCK PCDHGB7 PCDHGB3 PCDHGA7 PCDHGA12 PCDHGB4	5.79e-05	71	279	6	EFO_0007878, EFO_0007979
Disease	Ciliopathies	CDH23 ADGRV1 PCDH15 AIPL1 LRRC56 XPNPEP3 TTC21B	8.70e-05	110	279	7	C4277690
Disease	USHER SYNDROME, TYPE ID	CDH23 PCDH15	8.91e-05	2	279	2	601067
Disease	Usher syndrome type 1D (is_implicated_in)	CDH23 PCDH15	8.91e-05	2	279	2	DOID:0110831 (is_implicated_in)
Disease	Usher syndrome, type 1D	CDH23 PCDH15	8.91e-05	2	279	2	C2931208
Disease	USHER SYNDROME, TYPE ID	CDH23 PCDH15	8.91e-05	2	279	2	C1832845
Disease	1-stearoylglycerol 1-monostearin measurement	SYNE2 KIAA1549	8.91e-05	2	279	2	EFO_0021111
Disease	Usher syndrome type 1D	CDH23 PCDH15	8.91e-05	2	279	2	cv:C1832845
Disease	myocardial infarction	TDRD15 TMOD4 CA10 IL1F10 MERTK NOS3 FN1 SASH1 VEPH1 APOB UNC5C RASGEF1B	1.39e-04	350	279	12	EFO_0000612
Disease	Kidney Diseases	RASAL1 NPHS1 TERT SLC12A3 TTC21B IFT122	1.92e-04	88	279	6	C0022658
Disease	esterified cholesterol measurement, low density lipoprotein cholesterol measurement	TDRD15 APOB ANKRD17	2.82e-04	14	279	3	EFO_0004611, EFO_0008589
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	TDRD15 PDE3A MFHAS1 SYNE2 USP1 SEC16B APOB INTS10 MACF1	2.82e-04	222	279	9	EFO_0008317, EFO_0020943
Disease	transient cerebral ischemia (implicated_via_orthology)	NOS3 VWF SIN3A TERT ELANE	3.53e-04	64	279	5	DOID:224 (implicated_via_orthology)
Disease	obsolete_red blood cell distribution width	SPTB RGPD1 CDH23 AK9 ST7L DCK AK3 ABCB4 AP2B1 SYNE2 NUP210 RWDD1 SCAPER TBC1D12 PLD1 FKBP8 AGAP1 USP36 E2F2 APOB TRIM10 INTS10 CD22 NT5C2 ADGRD2 EIF2AK4	4.88e-04	1347	279	26	EFO_0005192
Disease	immature platelet count	ST7L AK3 AP2B1 VWF TERT SEC14L5	5.24e-04	106	279	6	EFO_0803544
Disease	Cholestasis, progressive familial intrahepatic 1	MYO5B ABCB4	5.28e-04	4	279	2	C4551898
Disease	neutrophil elastase measurement	ATP8B4 ELANE	5.28e-04	4	279	2	EFO_0020605
Disease	Short QT Syndrome 1	KCNJ2 CACNA2D1	5.28e-04	4	279	2	C1865020
Disease	mean platelet volume	ATP8B4 SRCAP ST7L RIMKLB AP2B1 SYNE2 MVP NOS3 LNX2 VWF PCDHGB7 PCDHGB3 PCDHGA7 SIN3A EBF1 TERT MAPRE1 FRY PCDHGA12 PCDHGB4 SEC14L5	7.65e-04	1020	279	21	EFO_0004584
Disease	USHER SYNDROME, TYPE IB (disorder)	CDH23 PCDH15	8.74e-04	5	279	2	C1848638
Disease	USHER SYNDROME, TYPE IA, FORMERLY	CDH23 PCDH15	8.74e-04	5	279	2	C1848639
Disease	USHER SYNDROME, TYPE I, FRENCH VARIETY, FORMERLY	CDH23 PCDH15	8.74e-04	5	279	2	C1848640
Disease	Usher syndrome, type 1A	CDH23 PCDH15	8.74e-04	5	279	2	C2931205
Disease	Usher syndrome type 1	CDH23 PCDH15	8.74e-04	5	279	2	cv:C1568247
Disease	Disorder of eye	CDH23 ADGRV1 PCDH15 AIPL1 MERTK OAT TTC21B SNRNP200	9.74e-04	212	279	8	C0015397
Disease	fumarate measurement	RPS6KA2 RFTN1 LARS2	9.80e-04	21	279	3	EFO_0010480
Disease	cholesterol:total lipids ratio, intermediate density lipoprotein measurement	TDRD15 SYNE2 USP1 APOB INTS10 MACF1	1.05e-03	121	279	6	EFO_0008595, EFO_0020943
Disease	developmental disorder of mental health (implicated_via_orthology)	SRCAP DLG2 SIN3A RNF2	1.19e-03	49	279	4	DOID:0060037 (implicated_via_orthology)
Disease	Sarcosine measurement	PCDHGB3 PCDHGA7 PCDHGB4	1.29e-03	23	279	3	EFO_0021668
Disease	diabetic angiopathy (implicated_via_orthology)	PTK2B FN1	1.30e-03	6	279	2	DOID:11713 (implicated_via_orthology)
Disease	Sjogren-Larsson syndrome (implicated_via_orthology)	ALDH3B1 ALDH3B2	1.30e-03	6	279	2	DOID:14501 (implicated_via_orthology)
Disease	familial combined hyperlipidemia (is_marker_for)	VWF APOB	1.30e-03	6	279	2	DOID:13809 (is_marker_for)
Disease	Usher Syndrome, Type I	CDH23 PCDH15	1.30e-03	6	279	2	C1568247
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	TDRD15 PDE3A MFHAS1 USP1 SEC16B APOB INTS10 MACF1	1.42e-03	225	279	8	EFO_0008317, EFO_0020947
Disease	serum albumin measurement	ADGRV1 ITIH1 IL1F10 DOCK3 NPHS1 CACNA2D1 COL7A1 EBF1 TERT HSPB9 FRY MACF1 EIF2AK4 SOS1	1.65e-03	592	279	14	EFO_0004535
Disease	mental development measurement	PCDHGB3 PCDHGA7 PCDHGB4	1.65e-03	25	279	3	EFO_0008230
Disease	pulse pressure measurement	TDRD15 PDE3A ATP8B4 MFHAS1 SRCAP MAST2 ITIH1 EBF2 FNDC1 RBM25 SPATA17 TBC1D12 ASCC2 LOXL4 USP36 FN1 TTI2 ARHGEF12 PCDHAC1 EBF1 NT5C2 EIF2AK4 PALLD CDH17 FILIP1L	1.70e-03	1392	279	25	EFO_0005763
Disease	serum metabolite measurement	TDRD15 PDE3A ACY3 PKD1L2 GFUS ABCB4 EBF2 SLC38A2 PHKB HSPA12A SYNE2 PCDH15 LOXL4 ALDH3B2 USP1 CACNA2D1 RAE1 VEPH1 APOB	1.77e-03	945	279	19	EFO_0005653
Disease	Hereditary retinal dystrophy	CDH23 PCDH15	1.81e-03	7	279	2	C0154860
Disease	fish oil supplement exposure measurement, high density lipoprotein cholesterol measurement	INTS10 SLC12A3	1.81e-03	7	279	2	EFO_0004612, EFO_0600007
Disease	Cerebral ventriculomegaly	SIN3A IFT122	1.81e-03	7	279	2	C1531647
Disease	Communicating Hydrocephalus	SIN3A IFT122	1.81e-03	7	279	2	C0009451
Disease	Fetal Cerebral Ventriculomegaly	SIN3A IFT122	1.81e-03	7	279	2	C2936718
Disease	Obstructive Hydrocephalus	SIN3A IFT122	1.81e-03	7	279	2	C0549423
Disease	Usher syndrome	CDH23 PCDH15	1.81e-03	7	279	2	cv:C0271097
Disease	Hydrocephalus Ex-Vacuo	SIN3A IFT122	1.81e-03	7	279	2	C0270720
Disease	Post-Traumatic Hydrocephalus	SIN3A IFT122	1.81e-03	7	279	2	C0477432
Disease	retinal detachment	COL22A1 CDH19	1.81e-03	7	279	2	EFO_0005773
Disease	level of Sterol ester (27:1/18:2) in blood serum	TDRD15 APOB ANKRD17	1.85e-03	26	279	3	OBA_2045194
Disease	lifestyle measurement	CA10 CAMKV FUBP1 PCDH15 DOCK3 IPO8 RIT2 RASGEF1B	1.87e-03	235	279	8	EFO_0010724
Disease	Degenerative polyarthritis	DDX3X MVP PPP2R1A EEF2 TRAP1	1.92e-03	93	279	5	C0029408
Disease	Osteoarthrosis Deformans	DDX3X MVP PPP2R1A EEF2 TRAP1	1.92e-03	93	279	5	C0086743
Disease	susceptibility to pneumonia measurement	GNL1 ARHGAP6 AIFM2 UNC5C LSM2	2.32e-03	97	279	5	EFO_0008410
Disease	S-warfarin measurement	RFTN1 ZNF534 MAN2B2 TTI2 EIF2AK4	2.32e-03	97	279	5	EFO_0803323
Disease	Fanconi anemia (implicated_via_orthology)	FANCD2 USP1	2.40e-03	8	279	2	DOID:13636 (implicated_via_orthology)
Disease	Aqueductal Stenosis	SIN3A IFT122	2.40e-03	8	279	2	C2936786
Disease	esterified cholesterol measurement, intermediate density lipoprotein measurement	TDRD15 APOB	2.40e-03	8	279	2	EFO_0008589, EFO_0008595
Disease	Congenital Hydrocephalus	SIN3A IFT122	2.40e-03	8	279	2	C0020256
Disease	urate measurement, bone density	DCK CA10 FNDC1 SPATA17 KIDINS220 GBP5 DLG2 UTRN RASAL1 ZNF695 ABCB5 PREPL EIF2AK4 KCNH5	2.48e-03	619	279	14	EFO_0003923, EFO_0004531
Disease	1,5 anhydroglucitol measurement	PKD1L2 MGAM2 PCDHAC1	2.55e-03	29	279	3	EFO_0008009
Disease	aspartate aminotransferase measurement	PDE3A CACNA2D2 MFHAS1 ST7L DCK ITIH1 ABCB4 HSPA12A IL1F10 SEPTIN14 LOXL4 MERTK AGAP1 NPTN PCDHGB4 ALPK2 TJP3 SOS1	2.58e-03	904	279	18	EFO_0004736
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	TDRD15 MFHAS1 SYNE2 USP1 APOB INTS10 MACF1	3.05e-03	200	279	7	EFO_0004611, EFO_0020945
Disease	cystic fibrosis (implicated_via_orthology)	ABCB4 ABCB5	3.07e-03	9	279	2	DOID:1485 (implicated_via_orthology)
Disease	level of Sphingomyelin (d36:1) in blood serum	ANKRD17 KCNH5	3.07e-03	9	279	2	OBA_2045178
Disease	glucose metabolism decline measurement, cingulate cortex measurement	CDH23 TYW1	3.07e-03	9	279	2	EFO_0007738, EFO_0009392
Disease	Hydrocephalus	SIN3A IFT122	3.07e-03	9	279	2	C0020255
Disease	triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement	TDRD15 MFHAS1 SYNE2 APOB INTS10 MACF1	3.11e-03	150	279	6	EFO_0004611, EFO_0020947
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	TDRD15 MFHAS1 SYNE2 USP1 SEC16B APOB INTS10 MACF1	3.81e-03	264	279	8	EFO_0008317, EFO_0020944
Disease	cystic kidney disease (implicated_via_orthology)	IFT172 TTC21B	3.81e-03	10	279	2	DOID:2975 (implicated_via_orthology)
Disease	Erectile dysfunction	GRIN3A NOS3	3.81e-03	10	279	2	C0242350
Disease	pack-years measurement, systolic blood pressure	RPS6KA2 CDH19 FRY	4.03e-03	34	279	3	EFO_0006335, EFO_0006526
Disease	gestational age, parental genotype effect measurement	CACNA2D1 EBF1 SOS1	4.38e-03	35	279	3	EFO_0005112, EFO_0005939
Disease	brain ischemia (implicated_via_orthology)	PTK2B NOS3 SOS1	4.38e-03	35	279	3	DOID:2316 (implicated_via_orthology)
Disease	cardiovascular disease	TDRD15 EBF2 DLG2 NOS3 USP36 ARHGEF18 APOB EBF1 MTRF1 UNC5C NT5C2	4.43e-03	457	279	11	EFO_0000319
Disease	Shortened QT interval	KCNJ2 CACNA2D1	4.63e-03	11	279	2	C0151879
Disease	Jeune thoracic dystrophy	IFT172 TTC21B	4.63e-03	11	279	2	C0265275
Disease	Tachycardia, Ventricular	KCNJ2 NOS3	4.63e-03	11	279	2	C0042514
Disease	spontaneous preterm birth, parental genotype effect measurement	CACNA2D1 SOS1	4.63e-03	11	279	2	EFO_0005939, EFO_0006917
Disease	beta thalassemia (is_marker_for)	APOB TERT	4.63e-03	11	279	2	DOID:12241 (is_marker_for)
Disease	Cardiovascular Diseases	NOS3 VWF APOB	4.74e-03	36	279	3	C0007222
Disease	eye morphology measurement	ZNF131 CDH23 CA10 ABCB4 IPO8 FRY EMC2	4.88e-03	218	279	7	EFO_0007858
Disease	Disease Exacerbation	ABCB4 COL7A1 E2F2 TERT PPP2R1A TRAP1	4.96e-03	165	279	6	C0235874
Disease	reading and spelling ability	CACNA2D1 SASH1 LIPF RIT2 SLC12A3 PCDH9	5.10e-03	166	279	6	EFO_0005301
Disease	Abnormality of refraction	PDE3A MYO5B DDX3X ASCC2 DLG2 UTRN DOCK3 PCLO ATP6V1E2 PCDHAC1 EBF1 FRY THBS4 PCDH9	5.16e-03	673	279	14	HP_0000539
Disease	amino acid measurement	GLRX5 RPS6KA2 CA10 DLG2 MGAM2 CACNA2D1 FAT4 MED10 VWF LRRN1 LIG1 ELANE APPL1 AP4B1	5.50e-03	678	279	14	EFO_0005134
Disease	age of onset of multiple sclerosis	LRRC56 CDH17	5.52e-03	12	279	2	OBA_2001029
Disease	hepatocyte growth factor-like protein measurement	CACNA2D2 DOCK3 CELSR3	5.53e-03	38	279	3	EFO_0008154
Disease	immature platelet measurement	ST7L AP2B1 DOCK3 VWF SEC14L5	5.55e-03	119	279	5	EFO_0803541
Disease	C-reactive protein measurement	TDRD15 MFHAS1 IFT172 LIME1 PTPN2 HSPA12A RBM25 IL1F10 CAMKV PCDH15 MERTK DOCK3 SEC16B MAP3K8 APOB CEP192 EBF1 CYFIP2 RIT2 XPNPEP3 MACF1	5.56e-03	1206	279	21	EFO_0004458
Disease	reticulocyte measurement	SPTB ABCB4 RBM25 RIMKLB AP2B1 SYNE2 ASCC2 PLD1 USP48 GNL1 VWF E2F2 EBF1 SBNO2 TRIM10 PCDHGB4 NT5C2 ADGRD2 EIF2AK4	5.70e-03	1053	279	19	EFO_0010700
Disease	age at first birth measurement	CAMKV DOCK3 JADE2 LARS2 PCDH9	5.75e-03	120	279	5	EFO_0009101
Disease	progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian carcinoma	BLACE OPTC INTS10	5.94e-03	39	279	3	EFO_0001075, EFO_0004920, GO_0097328, MONDO_0009354
Disease	thioredoxin domain-containing protein 12 measurement	DOCK3 COL7A1 CELSR3	5.94e-03	39	279	3	EFO_0008298
Disease	sleep duration, high density lipoprotein cholesterol measurement	MYO5B APOB INTS10 SLC12A3 MACF1	5.95e-03	121	279	5	EFO_0004612, EFO_0005271
Disease	multiple system atrophy	EBF2 LOXL4 USP48	6.38e-03	40	279	3	EFO_1001050
Disease	Short Rib-Polydactyly Syndrome	IFT172 TTC21B	6.49e-03	13	279	2	C0036996
Disease	Nephronophthisis	XPNPEP3 TTC21B	6.49e-03	13	279	2	C0687120

Protein segments in the cluster

Peptide	Gene	Start	Entry
LAVGNELNITPELYE	TBC1D12	496	O60347
LEPEEAIVAYEQALN	TTC21B	736	Q7Z4L5
YPIAVLIDELRNEDV	PPP2R1A	11	P30153
EEIPILRYVSGDDLL	ERICH6	581	Q7L0X2
GYVDNIEDLRIIEPI	EDDM3A	131	Q14507
LVDDPLEYQAGLLVQ	AKAP2	561	Q9Y2D5
ARGVRELVQNEIYPI	CARD10	926	Q9BWT7
YPVLVERIIQNTEAG	ARHGEF18	606	Q6ZSZ5
IELLQVDAPSDYQRE	AIPL1	151	Q9NZN9
DPYEVTRARELNQLL	ACY3	86	Q96HD9
YELLERVEEPVLQNQ	AGAP1	31	Q9UPQ3
QPLEQLTRYGRLLEE	ARHGEF40	1206	Q8TER5
LLSGEPEVQYVALRN	AP2B1	291	P63010
VYESLIEQSLPNERF	BLACE	151	A4D250
ESYGRPEEQVLINRQ	CATSPER4	51	Q7RTX7
QITNERGEPSYDRLI	CTAGE4	571	Q8IX94
QITNERGEPSYDRLI	CTAGE8	571	P0CG41
QITNERGEPSYDRLI	CTAGE9	571	A4FU28
VAPTRELVNQIYLEA	DDX4	371	Q9NQI0
EIPSIGAIRINTQEY	CACNA2D2	451	Q9NY47
EGQDYVETVIPSNRL	EIF2AK4	556	Q9P2K8
ELTVERLVSIGYPQE	NT5C2	71	P49902
ENNIPYATVEEELIG	ALPK2	2021	Q86TB3
VQLLQRLYDPDDGFI	ABCB5	431	Q2M3G0
ESDRYIAPTVLVDVQ	ALDH3B1	311	P43353
DNIPALVEEYLERAT	ASCC2	46	Q9H1I8
YDPEQVINNILEERL	ASCC2	496	Q9H1I8
AELDRETLPIYNLSV	FAT4	3466	Q6V0I7
RSEVLNIYVLDDDIP	ADGRV1	1641	Q8WXG9
VNELYSLLRDQDPIV	AP4B1	161	Q9Y6B7
LALYDRQGQPVEIER	EBF2	71	Q9HAK2
YGSQEPLAALLEEVI	DEPDC1B	446	Q8WUY9
ELIYQVQSPDEGALV	ATP8B4	486	Q8TF62
SDRYIAPTVLVDVQE	ALDH3B2	231	P48448
LSEGDYARLQQVDPV	ANKRD17	921	O75179
YVGALRENEPSVTQL	CDH23	566	Q9H251
IDVRYLADTEDNPIQ	CFAP44	796	Q96MT7
LSEYPNVEELRNLDL	ARHGEF12	1001	Q9NZN5
EIVELSEPLQVVRYG	P4HTM	306	Q9NXG6
PEVSQELYDLNVELS	RBFA	111	Q8N0V3
GLIVYQLENQPSEFR	RAE1	191	P78406
DPDAEAQTVYRQLLL	RASAL1	721	O95294
IEVLIREYSSELNAP	RBM25	211	P49756
LYPIDVEIIDINDNV	PCDHGA7	116	Q9Y5G6
LPEENREAAYNAITL	RAD21	96	O60216
LEGVEVQTDYVPLLN	RFTN1	381	Q14699
YERIFILLEEVQGPL	INTS6L	796	Q5JSJ4
RPLGFTEEVEVILQY	ITGB1	446	P05556
LGVRLYSEEQPQEAV	P3H1	211	Q32P28
TDIVLDREQVPSYNI	PCDHGA12	406	O60330
IEEAQRSYILTQGPL	PTPN2	76	P17706
SQVPLVLLEDVSNVY	INTS10	341	Q9NVR2
YQDIRINHTVILDDP	PPIL4	151	Q8WUA2
AVLDREQNPEYNITV	PCDHGB4	406	Q9UN71
ILTQQPLDFEEVERY	PCDHGB7	301	Q9Y5F8
EYIPLDQIDINVGFD	KCNJ2	241	P63252
PVQLIYFVEDQDGER	KIAA1549	1236	Q9HCM3
SYVRDDAVPNLIQLI	AP1G1	431	O43747
YVSDNIRIETVLPAE	NUP210	381	Q8TEM1
PIITLVALDEALDNY	NUP210	1026	Q8TEM1
VLAPTRELAVQIYEE	DDX3X	271	O00571
DLRNVGPVDAQVYLE	DNAJC24	86	Q6P3W2
PGLDREQLYLELSQL	MUC16	13871	Q8WXI7
NVLYRPEFLGEQVLV	NPHS1	641	O60500
GPSLQLEDVNIEELY	IL1F10	76	Q8WWZ1
IVQDLLDAGTYVNIP	KIDINS220	251	Q9ULH0
QVPTRNVVGYDLDLD	KLHL34	586	Q8N239
ELREDGFQPQTYLVQ	KDM7A	416	Q6ZMT4
YTLPRLNQEEVESLN	nan	436	O00370
LVQETAYLEDRPLSQ	LOXL4	541	Q96JB6
DAEDVIVNRYIQEIP	IFT122	201	Q9HBG6
GLNLRVIDPQADTYN	MAGEE2	141	Q8TD90
VVRYVQLPADEVDTQ	LSM2	66	Q9Y333
PEQVVQEYLELVGRP	MGAM2	311	Q2M2H8
LDNNRIRYLPDSIVE	MFHAS1	326	Q9Y4C4
VDVDLQYPQDAVLAL	ITIH1	481	P19827
LPDVRNQADVIYVNT	MERTK	861	Q12866
SQYLLPILEQDGIEN	LRSAM1	216	Q6UWE0
GTPQQIDYARQLIEE	FUBP1	431	Q96AE4
LETLGIQEDPQDYLL	GAB1	171	Q13480
GQQQLDVRDPERVSY	HSPB9	81	Q9BQS6
QIYLSENPEETAARV	APPL1	376	Q9UKG1
LAEVLQLGSDILPQY	KCNH5	181	Q8NCM2
LPQAEALDRAYQIDT	AK3	96	Q9UIJ7
PLINIVIQEVYRDGV	LNX2	256	Q8N448
IYDVGEQIAVPRNDE	DYNC1I2	596	Q13409
VIVLAGRPVYQDEQE	GJD4	36	Q96KN9
PEDNVVIIYLSRAGN	ISLR	381	O14498
RLQQLEEDFYELVEP	JADE2	396	Q9NQC1
QRLNEEARTYVLAPE	MAP3K6	1196	O95382
PQNGRYQIDSDVLLI	MAP3K8	116	P41279
QGTYLLVDPNEREER	EXOSC9	201	Q06265
VVTEDGYILEVNRIP	LIPF	51	P07098
HTPRNYVLIDDIGEI	PCLO	4041	Q9Y6V0
TQIALEPEQILRYGR	PDCD2	246	Q16342
RSPEGLRLIYNIVEE	FAT2	2196	Q9NYQ8
EQLDLPVRQAGVIYL	IPO7	46	O95373
IVPDLDLQQVNYDVD	MORC3	906	Q14149
LRNDVLNPDNYGEVI	OPTC	46	Q9UBM4
AIAQELIYTIREELP	PCDH9	21	Q9HC56
IIEVNGVNVLDEPYE	PDZK1P1	306	A8MUH7
LARYVEQILPQSAEA	PDE3A	251	Q14432
SIYNRLLAIEDIDPT	CSTF3	361	Q12996
EEYTFIQNVPLEDRV	HNRNPU	471	Q00839
AEDPLVQSLRQELYV	LSS	251	P48449
NILIEIAVYEPVALN	VEPH1	256	Q14D04
GPLQAYLRQNDLDIE	EP400P1	401	Q6ZTU2
GQLVTPDEYLENSLR	GBP5	191	Q96PP8
LREYNEVEPIILSVG	GFUS	231	Q13630
ELLELDIREVYQPGS	GNL1	111	P36915
NQDGYRELVTEALPL	LRRC46	146	Q96FV0
LVEDTLYQGLPAEVR	LRRC8E	776	Q6NSJ5
EQLIIALEPEAASIY	HSPA12A	231	O43301
ITVPLEVFEYIDQGR	MED10	61	Q9BTT4
TDGALDREQIPEYNV	PCDHGB3	406	Q9Y5G1
EPVINALLDNGTRYN	PPP4R3B	616	Q5MIZ7
TDVNDNVPSIDIRYI	PCDH11X	346	Q9BZA7
GQNRLYQPEEIILVS	PRSS54	371	Q6PEW0
QQLEVIPGYEELLAD	CYFIP2	226	Q96F07
NPLLGETYELVRDDL	OSBPL1A	626	Q9BXW6
IELERLNYIGPEEFV	RASGEF1B	216	Q0VAM2
DIPRELVVGIYERIQ	IQSEC3	821	Q9UPP2
RESLPELQIEIIADY	MMACHC	91	Q9Y4U1
LDYEERVLPSIVNEV	PHB2	126	Q99623
VPYVLIGTQIDLRDD	RHOJ	126	Q9H4E5
ERQAIPLDENEGIYV	MVP	376	Q14764
QEVLQALEPQVDYLR	MACF1	5061	Q9UPN3
DINSLLALVEDVIYP	PKD1L2	1686	Q7Z442
RPEDVSVLYITQAQE	IFT172	966	Q9UG01
STTVQLIQRLYDPDE	ABCB4	436	P21439
LIQRLYDPDEGTINI	ABCB4	441	P21439
NYLREIIGVVSQEPV	ABCB4	466	P21439
NRVEGLLPYNLSLEV	GRIN3A	136	Q8TCU5
EQQELEALSQDPRRY	NOS3	886	P29474
INVLEDPGYLDLTQI	PPM1E	561	Q8WY54
EDLLNNGQPRLTYEE	PALLD	916	Q8WX93
GPLDREQISEYQVLI	PCDHAC1	401	Q9H158
YTAFINTLLLEPEEQ	ARHGAP6	486	O43182
DVIDNGNYDIEIRQP	PRICKLE1	636	Q96MT3
QREDTLVYLVSQAPD	ITPRIPL1	371	Q6GPH6
DLTEILDRYVQEQIP	PCDH15	1266	Q96QU1
YPELVLNQVLDREEI	PCDHB7	191	Q9Y5E2
GVTIDLINPDTYRID	PAF1	81	Q8N7H5
DYLQQVSELINRTEP	EEF1AKMT4-ECE2	486	P0DPD8
LELELRPTGEIEQYS	APOB	1001	P04114
RNIQEYLSILTDPDG	APOB	4446	P04114
YLIEPDVELQRIASI	ARMC8	306	Q8IUR7
LAQQGEYSEAIPILR	FKBP8	316	Q14318
AAYNVLDDPELRQGI	GLRX5	86	Q86SX6
SLNVPSEEEVYRAVL	KLHL17	246	Q6TDP4
QPSEVTDRYDLGQVI	CAMKV	16	Q8NCB2
RLEVPDRTEDNLQIY	E2F2	276	Q14209
NRGQYETVVPLEDSI	DOCK3	71	Q8IZD9
EPLNLFYIERDTGNL	DSC3	181	Q14574
EELVEYLPQLQVAEQ	CCDC175	556	P0C221
DLYTVEPNNARQLVE	CACNA2D1	66	P54289
YEIPSIGAIRINTQE	CACNA2D1	411	P54289
IPLERAVINGQLYEE	FILIP1L	816	Q4L180
YTIQVLRDGQERDAP	FN1	1151	P02751
YAPQVIEDNGVRRVV	FNDC3A	81	Q9Y2H6
LIENLIPDTVYEFAV	FNDC1	321	Q4ZHG4
QQLSPEVERETTDYL	CPAMD8	1166	Q8IZJ3
EGAYEAELIVSIPLQ	ITGAV	666	P06756
VLALYDRQGQPVEIE	EBF1	71	Q9UH73
IDQYSIPQVSIRLDG	COL22A1	316	Q8NFW1
DLLENLTQGEIIYPE	LYST	1256	Q99698
YQEFNSDIIDILRTP	LYST	2656	Q99698
DPVLQRIVDILYATD	MAPRE1	236	Q15691
EQEYQAGPLELNREA	MAN2B2	701	Q9Y2E5
YIVSQLGLTRDPLEE	MAST2	461	Q6P0Q8
FQDELLVTEVYDLPQ	CEP192	2026	Q8TEP8
LQEIYLQAEEQEVLP	CXorf38	251	Q8TB03
DYLQEVPILTLDVNE	DCK	226	P27707
VLPSDVTRYQLDGLQ	COL7A1	461	Q02388
ENGYDPVNLLNDIVI	ELANE	106	P08246
GQEDLILSYEPVTRQ	DLG2	661	Q15700
QIQDLRPEDSGIYQV	IGFN1	276	Q86VF2
ELQLEPEELYQTFQR	EEF2	166	P13639
AIQLYDRILQEDPTN	EMC2	106	Q15006
ETPIIGRRYDELQNS	FRY	2336	Q5TBA9
PQYGIAREDVVLNRI	PTK2B	416	Q14289
TLRENVEEGYPILQL	CELSR3	441	Q9NYQ7
VLALYDRQGQPVEIE	EBF3	71	Q9H4W6
IDQEGDIYVTQPLDR	CDH17	286	Q12864
LLQGLNIEELYPETS	CA10	216	Q9NS85
IEEQALIINAYPDNI	DCTN6	56	O00399
DLIYLNGESLVREPL	LIG1	661	P18858
RIIEVVEANYPETLG	SEC14L1	416	Q92503
EVVEDNYPETLGRLL	SEC14L5	406	O43304
TVYVPDENNTILGRN	SCAPER	1026	Q9BY12
QEEPVFYISILIADN	CDH19	541	Q9H159
LYELQRTPQEAITDG	RNF2	21	Q99496
GERPQAQENVDYVIL	CD22	831	P20273
GILDYLDNISPQQIR	FANCD2	516	Q9BXW9
LLVEDTLGNIDQPQY	PHKB	981	Q93100
VSVDRYALDNLPELT	LRRN1	301	Q6UXK5
VLLNEYNGIDLPVEN	PRDM2	891	Q13029
PELEDLARYDVGAIQ	RGPD1	406	P0DJD0
APLSEDQRTALQEVY	IPO8	981	O15397
LLSEPQELLVNYVSD	MCAM	331	P43121
LLAEERQENLPDEIY	NTMT1	201	Q9BV86
IPNLAILQIYDGDLE	FER1L6	1271	Q2WGJ9
LQNENELLPTYEIAE	RSPH4A	271	Q5TD94
NEQIEPIYALLRETE	GTF2E1	181	P29083
PIYALLRETEDVNLA	GTF2E1	186	P29083
LVQRPEDYLENVENI	AK9	226	Q5TCS8
QEYVELGDQLLVLQP	MOCS2	61	O96033
LIQRLYPEGGQLLDE	SESN2	351	P58004
QGPFRDITEVLEQRY	SPATA17	241	Q96L03
VELSLNVPELNTAIY	UTRN	1886	P46939
YLPVQTVLEGDNLET	UTRN	3151	P46939
EYELVQLLPGERELT	RGL2	696	O15211
VISQRYPDIRIEGEN	SELENOT	61	P62341
RIDLNEALTQPVYDQ	NUGGC	566	Q68CJ6
ISNGIQIYQLPTDEE	SEPTIN14	216	Q6ZU15
SEQRPRIQELGDLYT	PIH1D1	181	Q9NWS0
QYQEVPLDEAVTLRV	TMEM132A	246	Q24JP5
EIVSYQVELRLPQTG	SYNE2	3946	Q8WXH0
YRALLEGESNPEIVI	SYNM	311	O15061
LPSGQYLQREEVDLT	LARS2	606	Q15031
YLQREEVDLTGSVPV	LARS2	611	Q15031
IYELQREFLTVPQLG	TDRD15	1391	B5MCY1
SERVSNLEELPLNEY	AIFM2	206	Q9BRQ8
GEQLVEEYLSPARLQ	LRRC56	46	Q8IYG6
PSEEAINDRTVNYVL	PLEKHG4	1056	Q58EX7
RVVLGYLDDPSEDIQ	PLD1	961	Q13393
VRIDNEPAYLDILDT	RIT2	61	Q99578
TVQQPEASVLYEDLL	TAF1L	1751	Q8IZX4
DYLVTEEEINLTRGP	SYNJ2BP	6	P57105
VLFEEGLIQSLNYPE	OVCH2	436	Q7RTZ1
PLRYEASTNELINEE	PYURF	66	Q96I23
TENLVRELLAVPDNY	PSAT1	56	Q9Y617
QGQDLQYIFIPSDIR	ST6GALNAC2	221	Q9UJ37
PALTEQEVYAQVARL	SIN3A	351	Q96ST3
LAPGIEEIYEESQQV	SBNO2	1011	Q9Y2G9
EIAALVEQLTPIERY	SRCAP	2301	Q6ZRS2
QAALTRPEELSYEVI	OSCP1	331	Q8WVF1
RPEELSYEVINIQAT	OSCP1	336	Q8WVF1
LESDLYRAVQPSELV	SOS1	791	Q07889
AELAPLAAIYQEIQE	MTRF1	111	O75570
YRLEVPESVTVQEGL	SIGLEC12	151	Q96PQ1
RYLVLDIADNPVENI	STYX	81	Q8WUJ0
LAVDYENVRPDIVLL	OAT	276	P04181
EISEPRLQNYDENGR	STON2	481	Q8WXE9
EGQALYLVSPTEIQR	STXBP5L	1036	Q9Y2K9
ILLQIYEVQRGPEEE	ADGRD2	641	Q7Z7M1
YEVQRGPEEESLLRT	ADGRD2	646	Q7Z7M1
VPLILGQEYEDEERL	C1orf54	11	Q8WWF1
IEIGEDNRSIEPLTY	ASCC3	1801	Q8N3C0
LQETPRNYELGDVVE	RNF31	666	Q96EP0
RDDIYTLQINPDSAV	SMURF2	461	Q9HAU4
YDVGLNDIIQLLVRP	UHRF2	61	Q96PU4
RAYQTVVLDPEGDAQ	THBS4	731	P35443
VELVSLLEEQLPQYR	TRAK2	41	O60296
DPVNVIAATYDILIE	XYLT1	786	Q86Y38
YLTEDILPEQGLQVS	ZNF695	91	Q8IW36
YPTEQELLAVQRAVS	ZFR2	601	Q9UPR6
LVSQGDREQAPNLVY	VWF	1591	P04275
SPLYGLQSRVEELVE	TRPM5	691	Q9NZQ8
NSGELDPLYVVEVLL	MTREX	686	P42285
AQALQEVEESSRPYL	PROM2	401	Q8N271
VPLDQEAYSRIQAGE	SLC27A4	626	Q6P1M0
ERVLPASLVISDDYQ	TTI2	246	Q6NXR4
EQLVNAYGILRERPE	SPATC1	526	Q76KD6
RGVPVLDLYLAQQAE	TRABD2B	181	A6NFA1
YELPLVIQALTNIED	SLC38A2	171	Q96QD8
ILQVQEVPYVEENGR	TRPC5OS	31	A6NMA1
QGVFEELARDYVPQL	TBC1D9	646	Q6ZT07
NIVNLQITEDPGEYE	NPTN	301	Q9Y639
YRNLVSLGEDNVRPE	ZNF534	41	Q76KX8
EGLQYPQSLNFERIV	RRN3P1	106	Q2M238
TVRDLLQEYGAPIVD	SLC12A3	241	P55017
GIPEALVQRYAEDLD	SASH1	1121	O94885
LESLLELQAYPDVQA	ST7L	336	Q8TDW4
RDDELYILTNVGEPT	PREPL	306	Q4J6C6
GLEDRTLLENYQVPS	TAL2	86	Q16559
QLVLEEPSSIVQLDY	TECPR2	166	O15040
RINGELITAYPQVVV	RIMKLB	61	Q9ULI2
PLTEEGIAQIYQLIE	ARHGAP19	116	Q14CB8
QTDPEYLLLGQRLEG	SPTB	1131	P11277
ETVQNEVYLGLPIFR	YJU2	61	Q9BW85
GPLDREALLQYLEQQ	TMOD4	61	Q9NZQ9
VILSNQAGDPELYQR	SEC16B	531	Q96JE7
ELGLLDPVQRNLYQD	ZNF234	21	Q14588
IEIISNAAEYENIPI	SNRNP200	1846	O75643
LDVTPSAIERLNYVQ	TJP3	676	O95049
EPGLAQLLVDQIYEN	TRAP1	661	Q12931
EQPRQVRVSLDYEVG	TRIM10	426	Q9UDY6
PQAELYEAVLEIQRD	XPNPEP3	356	Q9NQH7
QDQEAPRDYLILAVV	TRARG1	96	Q8IXB3
LPEQVQVSYLEVGRI	ZNF131	516	P52739
RNLEPVTQLYVSVDA	TYW1	521	Q9NV66
LTEQLRDIQLENYTP	ULBP2	101	Q9BZM5
EEQRNELEALESIYP	RWDD1	6	Q9H446
RIEVGDVNPSETQYI	USP48	821	Q86UV5
ISRQQVEELFGPEDY	UNC5C	126	O95185
LQGDIPENILEELYE	ZFYVE26	111	Q68DK2
PENILEELYETLTQG	ZFYVE26	116	Q68DK2
EGQVQVRTLYLSVDP	PTGR2	36	Q8N8N7
ARQSEEQAPLVESYL	TUB	61	P50607
AYDTIPQDRLTEVIA	TERT	716	O14746
ILQEEGIDLPRYAVL	PPIP5K1	151	Q6PFW1
DPYLDVALEIRQAAN	USP36	266	Q9P275
PLNEEEARGVVENYN	USP1	626	O94782
QLRYQETLGPREALI	ZKSCAN8	56	Q15776
RLSRIVEDPEVYQGL	ATP6V1E2	101	Q96A05
RDPSEEIEILLRYGQ	RPS6KA2	451	Q15349
DSGPLENVYESIREL	LIME1	246	Q9H400
ISYRNTELELQDPGQ	MX2	171	P20592
LNLYTPLNEFEERVT	MYO5B	1776	Q9ULV0